This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-106b-5p | APC | 1.71 | 0 | -0.24 | 0.1992 | miRNAWalker2 validate; miRTarBase | -0.14 | 0.00091 | 23087084 | miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells |
2 | hsa-miR-107 | APC | 0.9 | 5.0E-5 | -0.24 | 0.1992 | miRanda | -0.16 | 0.00649 | NA | |
3 | hsa-miR-320b | APC | 1.11 | 0.0005 | -0.24 | 0.1992 | miRanda | -0.16 | 9.0E-5 | NA | |
4 | hsa-miR-20a-3p | APC2 | 1.14 | 0.00045 | -1.51 | 0.00013 | mirMAP | -0.27 | 0.0021 | NA | |
5 | hsa-miR-221-5p | APC2 | 1.89 | 0 | -1.51 | 0.00013 | mirMAP | -0.34 | 4.0E-5 | NA | |
6 | hsa-miR-345-5p | APC2 | 1.84 | 0 | -1.51 | 0.00013 | mirMAP | -0.29 | 0.00069 | NA | |
7 | hsa-miR-625-5p | APC2 | 0.54 | 0.2038 | -1.51 | 0.00013 | mirMAP | -0.31 | 0 | NA | |
8 | hsa-miR-205-5p | AXIN2 | 3.14 | 0.02932 | -0.66 | 0.25177 | miRNATAP | -0.17 | 0 | NA | |
9 | hsa-miR-34c-5p | AXIN2 | 2.21 | 0.00038 | -0.66 | 0.25177 | miRanda | -0.21 | 0.00103 | NA | |
10 | hsa-miR-944 | AXIN2 | 3.33 | 0.01778 | -0.66 | 0.25177 | MirTarget; PITA; miRNATAP | -0.2 | 0 | NA | |
11 | hsa-miR-103a-3p | BTRC | 0.84 | 0 | -0.39 | 0.00796 | MirTarget; miRNATAP | -0.19 | 0.00257 | NA | |
12 | hsa-miR-148b-5p | BTRC | 1.04 | 0.00196 | -0.39 | 0.00796 | mirMAP | -0.11 | 0.0005 | NA | |
13 | hsa-miR-15a-5p | BTRC | 1.04 | 0 | -0.39 | 0.00796 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.19 | 0.00011 | NA | |
14 | hsa-miR-15b-5p | BTRC | 1.62 | 0 | -0.39 | 0.00796 | MirTarget; miRNATAP | -0.11 | 0.00209 | NA | |
15 | hsa-miR-16-1-3p | BTRC | 1.43 | 0 | -0.39 | 0.00796 | mirMAP | -0.1 | 0.00835 | NA | |
16 | hsa-miR-16-5p | BTRC | 1.01 | 1.0E-5 | -0.39 | 0.00796 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.15 | 0.00163 | NA | |
17 | hsa-miR-320a | BTRC | 0.59 | 0.0119 | -0.39 | 0.00796 | miRNAWalker2 validate; PITA | -0.16 | 0.00028 | NA | |
18 | hsa-miR-320b | BTRC | 1.11 | 0.0005 | -0.39 | 0.00796 | PITA | -0.11 | 0.00036 | NA | |
19 | hsa-miR-454-3p | BTRC | 0.63 | 0.01349 | -0.39 | 0.00796 | mirMAP | -0.19 | 0 | NA | |
20 | hsa-miR-505-3p | BTRC | 0.83 | 0.00112 | -0.39 | 0.00796 | MirTarget | -0.12 | 0.00372 | NA | |
21 | hsa-miR-195-3p | CACYBP | -1.35 | 2.0E-5 | 0.91 | 0 | mirMAP | -0.2 | 0 | NA | |
22 | hsa-miR-30a-3p | CACYBP | -1.73 | 0 | 0.91 | 0 | MirTarget | -0.16 | 2.0E-5 | NA | |
23 | hsa-miR-130b-5p | CAMK2A | 0.7 | 0.05101 | -0.13 | 0.82753 | mirMAP | -0.37 | 0.00178 | NA | |
24 | hsa-miR-142-5p | CAMK2A | 1.56 | 1.0E-5 | -0.13 | 0.82753 | PITA; miRNATAP | -0.46 | 0.00015 | NA | |
25 | hsa-miR-144-3p | CAMK2A | -0.13 | 0.79825 | -0.13 | 0.82753 | mirMAP | -0.3 | 0.00022 | NA | |
26 | hsa-miR-148a-3p | CAMK2A | -1.54 | 4.0E-5 | -0.13 | 0.82753 | miRNATAP | -0.32 | 0.00397 | NA | |
27 | hsa-miR-148b-5p | CAMK2A | 1.04 | 0.00196 | -0.13 | 0.82753 | mirMAP | -0.38 | 0.00256 | NA | |
28 | hsa-miR-15b-3p | CAMK2A | 1.76 | 0 | -0.13 | 0.82753 | mirMAP | -0.51 | 9.0E-5 | NA | |
29 | hsa-miR-19b-1-5p | CAMK2A | 1.39 | 0 | -0.13 | 0.82753 | mirMAP | -0.61 | 2.0E-5 | NA | |
30 | hsa-miR-25-3p | CAMK2A | 1.01 | 0.00042 | -0.13 | 0.82753 | MirTarget | -0.53 | 0.00031 | NA | |
31 | hsa-miR-26a-5p | CAMK2A | -0.38 | 0.04425 | -0.13 | 0.82753 | miRNATAP | -0.94 | 3.0E-5 | NA | |
32 | hsa-miR-26b-5p | CAMK2A | -0.3 | 0.16008 | -0.13 | 0.82753 | miRNATAP | -1.07 | 0 | NA | |
33 | hsa-miR-30b-5p | CAMK2A | -0.43 | 0.05936 | -0.13 | 0.82753 | mirMAP | -0.87 | 0 | NA | |
34 | hsa-miR-30d-5p | CAMK2A | -0.55 | 0.01401 | -0.13 | 0.82753 | mirMAP | -0.95 | 0 | NA | |
35 | hsa-miR-30e-5p | CAMK2A | -0.57 | 0.01125 | -0.13 | 0.82753 | mirMAP | -0.64 | 0.0008 | NA | |
36 | hsa-miR-32-5p | CAMK2A | 0.42 | 0.10646 | -0.13 | 0.82753 | MirTarget | -0.95 | 0 | NA | |
37 | hsa-miR-320c | CAMK2A | 0.46 | 0.24061 | -0.13 | 0.82753 | mirMAP | -0.54 | 2.0E-5 | NA | |
38 | hsa-miR-335-5p | CAMK2A | 1.6 | 6.0E-5 | -0.13 | 0.82753 | mirMAP | -0.61 | 0 | NA | |
39 | hsa-miR-338-3p | CAMK2A | -0.96 | 0.01915 | -0.13 | 0.82753 | miRNATAP | -0.3 | 0.00432 | NA | |
40 | hsa-miR-361-3p | CAMK2A | -0.13 | 0.56605 | -0.13 | 0.82753 | mirMAP | -0.64 | 0.00126 | NA | |
41 | hsa-miR-3614-5p | CAMK2A | 1.1 | 0.00706 | -0.13 | 0.82753 | mirMAP | -0.43 | 3.0E-5 | NA | |
42 | hsa-miR-363-3p | CAMK2A | -1.17 | 0.01565 | -0.13 | 0.82753 | MirTarget | -0.29 | 0.0011 | NA | |
43 | hsa-miR-429 | CAMK2A | 1.4 | 0.009 | -0.13 | 0.82753 | miRNATAP | -0.27 | 0.0005 | NA | |
44 | hsa-miR-616-5p | CAMK2A | 0.83 | 0.03478 | -0.13 | 0.82753 | mirMAP | -0.32 | 0.00341 | NA | |
45 | hsa-miR-625-5p | CAMK2A | 0.54 | 0.2038 | -0.13 | 0.82753 | mirMAP | -0.51 | 0 | NA | |
46 | hsa-miR-7-1-3p | CAMK2A | 0.71 | 0.04123 | -0.13 | 0.82753 | MirTarget | -0.6 | 0 | NA | |
47 | hsa-miR-92a-3p | CAMK2A | 1.22 | 1.0E-5 | -0.13 | 0.82753 | MirTarget | -0.69 | 1.0E-5 | NA | |
48 | hsa-miR-29a-3p | CAMK2B | -0.11 | 0.61501 | -2.37 | 0.00126 | mirMAP | -0.76 | 0.00147 | NA | |
49 | hsa-miR-625-5p | CAMK2B | 0.54 | 0.2038 | -2.37 | 0.00126 | mirMAP | -0.64 | 0 | NA | |
50 | hsa-miR-197-3p | CAMK2D | 0.89 | 0.0002 | -0.67 | 0.00279 | miRNATAP | -0.18 | 0.00721 | NA | |
51 | hsa-miR-421 | CAMK2D | 1.81 | 0 | -0.67 | 0.00279 | miRNATAP | -0.15 | 0.00111 | NA | |
52 | hsa-miR-127-5p | CAMK2G | 0.68 | 0.02163 | -0.26 | 0.15921 | MirTarget; PITA; miRNATAP | -0.14 | 0.0014 | NA | |
53 | hsa-miR-16-2-3p | CAMK2G | 1.8 | 0 | -0.26 | 0.15921 | mirMAP | -0.15 | 0.00029 | NA | |
54 | hsa-miR-16-5p | CAMK2G | 1.01 | 1.0E-5 | -0.26 | 0.15921 | miRNAWalker2 validate | -0.18 | 0.00182 | NA | |
55 | hsa-miR-1976 | CAMK2G | 0.92 | 0.00012 | -0.26 | 0.15921 | MirTarget | -0.18 | 0.00078 | NA | |
56 | hsa-miR-484 | CAMK2G | 0.71 | 0.00234 | -0.26 | 0.15921 | mirMAP | -0.16 | 0.00418 | NA | |
57 | hsa-miR-590-3p | CAMK2G | 1.12 | 0.00016 | -0.26 | 0.15921 | miRanda | -0.17 | 0.00013 | NA | |
58 | hsa-miR-338-3p | CCND1 | -0.96 | 0.01915 | 0.62 | 0.1312 | miRNAWalker2 validate; miRTarBase; miRanda | -0.24 | 0.00086 | NA | |
59 | hsa-let-7a-3p | CCND2 | 0.5 | 0.04111 | -0.5 | 0.3 | mirMAP | -0.54 | 0.0001 | 20418948 | MicroRNA let 7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2 |
60 | hsa-let-7b-3p | CCND2 | 0.22 | 0.29604 | -0.5 | 0.3 | mirMAP | -0.46 | 0.00588 | NA | |
61 | hsa-miR-106b-5p | CCND2 | 1.71 | 0 | -0.5 | 0.3 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.42 | 9.0E-5 | NA | |
62 | hsa-miR-130b-5p | CCND2 | 0.7 | 0.05101 | -0.5 | 0.3 | mirMAP | -0.39 | 2.0E-5 | NA | |
63 | hsa-miR-141-3p | CCND2 | 1.46 | 0.00116 | -0.5 | 0.3 | MirTarget; TargetScan | -0.21 | 0.00436 | NA | |
64 | hsa-miR-15b-5p | CCND2 | 1.62 | 0 | -0.5 | 0.3 | miRNATAP | -0.44 | 0.00021 | NA | |
65 | hsa-miR-16-2-3p | CCND2 | 1.8 | 0 | -0.5 | 0.3 | mirMAP | -0.55 | 0 | NA | |
66 | hsa-miR-16-5p | CCND2 | 1.01 | 1.0E-5 | -0.5 | 0.3 | miRNAWalker2 validate; miRNATAP | -0.67 | 1.0E-5 | NA | |
67 | hsa-miR-181a-2-3p | CCND2 | 0.9 | 0.00083 | -0.5 | 0.3 | mirMAP | -0.38 | 0.00236 | NA | |
68 | hsa-miR-182-5p | CCND2 | 0.89 | 0.03106 | -0.5 | 0.3 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.32 | 9.0E-5 | NA | |
69 | hsa-miR-183-5p | CCND2 | 1.66 | 0.00052 | -0.5 | 0.3 | miRNATAP | -0.29 | 2.0E-5 | NA | |
70 | hsa-miR-19b-3p | CCND2 | 0.76 | 0.00653 | -0.5 | 0.3 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.32 | 0.00853 | NA | |
71 | hsa-miR-21-3p | CCND2 | 1.75 | 0 | -0.5 | 0.3 | mirMAP | -0.33 | 0.0051 | NA | |
72 | hsa-miR-224-3p | CCND2 | 1.52 | 0.0065 | -0.5 | 0.3 | mirMAP | -0.27 | 4.0E-5 | NA | |
73 | hsa-miR-26b-5p | CCND2 | -0.3 | 0.16008 | -0.5 | 0.3 | mirMAP; miRNATAP | -0.58 | 0.00034 | NA | |
74 | hsa-miR-301a-3p | CCND2 | 1.45 | 1.0E-5 | -0.5 | 0.3 | miRNAWalker2 validate | -0.38 | 0.0002 | NA | |
75 | hsa-miR-3065-3p | CCND2 | -1.04 | 0.02184 | -0.5 | 0.3 | MirTarget; miRNATAP | -0.2 | 0.00685 | NA | |
76 | hsa-miR-3065-5p | CCND2 | -0.24 | 0.63312 | -0.5 | 0.3 | mirMAP | -0.24 | 0.00057 | NA | |
77 | hsa-miR-424-5p | CCND2 | 1.09 | 0.00042 | -0.5 | 0.3 | miRNATAP | -0.39 | 0.0003 | NA | |
78 | hsa-miR-429 | CCND2 | 1.4 | 0.009 | -0.5 | 0.3 | miRNATAP | -0.19 | 0.002 | NA | |
79 | hsa-miR-450b-5p | CCND2 | 0.46 | 0.13274 | -0.5 | 0.3 | MirTarget; PITA; miRNATAP | -0.32 | 0.00413 | NA | |
80 | hsa-miR-590-3p | CCND2 | 1.12 | 0.00016 | -0.5 | 0.3 | miRanda; mirMAP | -0.33 | 0.00348 | NA | |
81 | hsa-miR-590-5p | CCND2 | 1.04 | 0.00027 | -0.5 | 0.3 | mirMAP | -0.41 | 0.00055 | NA | |
82 | hsa-miR-9-3p | CCND2 | 0.33 | 0.54111 | -0.5 | 0.3 | MirTarget; mirMAP; miRNATAP | -0.19 | 0.00361 | NA | |
83 | hsa-miR-93-5p | CCND2 | 1.75 | 0 | -0.5 | 0.3 | miRNATAP | -0.32 | 0.00244 | NA | |
84 | hsa-miR-96-5p | CCND2 | 1.14 | 0.00943 | -0.5 | 0.3 | TargetScan; miRNATAP | -0.33 | 3.0E-5 | NA | |
85 | hsa-miR-96-5p | CCND3 | 1.14 | 0.00943 | 0.04 | 0.88352 | TargetScan | -0.12 | 0.00328 | NA | |
86 | hsa-miR-140-5p | CHD8 | 0.21 | 0.303 | 0.08 | 0.52589 | miRanda | -0.16 | 0.0007 | NA | |
87 | hsa-miR-221-3p | CHD8 | 1.33 | 0 | 0.08 | 0.52589 | MirTarget; miRNATAP | -0.11 | 0.00136 | NA | |
88 | hsa-miR-222-3p | CHD8 | 1.39 | 0 | 0.08 | 0.52589 | MirTarget; miRNATAP | -0.11 | 0.00087 | NA | |
89 | hsa-miR-186-5p | CREBBP | 0.15 | 0.43471 | -0.11 | 0.45436 | mirMAP; miRNATAP | -0.14 | 0.00768 | NA | |
90 | hsa-miR-107 | CSNK1A1 | 0.9 | 5.0E-5 | -0.13 | 0.51313 | PITA; miRanda; miRNATAP | -0.29 | 0 | NA | |
91 | hsa-miR-126-5p | CSNK1A1 | 0.42 | 0.07532 | -0.13 | 0.51313 | mirMAP | -0.16 | 0.00576 | NA | |
92 | hsa-miR-148a-5p | CSNK1A1 | -0.69 | 0.0793 | -0.13 | 0.51313 | MirTarget | -0.16 | 0 | NA | |
93 | hsa-miR-186-5p | CSNK1A1 | 0.15 | 0.43471 | -0.13 | 0.51313 | miRNAWalker2 validate; miRNATAP | -0.27 | 0.00019 | NA | |
94 | hsa-miR-19a-3p | CSNK1A1 | 1.27 | 0.00011 | -0.13 | 0.51313 | mirMAP | -0.11 | 0.00763 | NA | |
95 | hsa-miR-2110 | CSNK1A1 | 0.76 | 0.0724 | -0.13 | 0.51313 | miRNATAP | -0.14 | 1.0E-5 | NA | |
96 | hsa-miR-29a-5p | CSNK1A1 | 0.59 | 0.02301 | -0.13 | 0.51313 | mirMAP | -0.15 | 0.00587 | NA | |
97 | hsa-miR-30a-5p | CSNK1A1 | -1.72 | 0 | -0.13 | 0.51313 | MirTarget; miRNATAP | -0.11 | 0.00528 | NA | |
98 | hsa-miR-30b-5p | CSNK1A1 | -0.43 | 0.05936 | -0.13 | 0.51313 | MirTarget; mirMAP; miRNATAP | -0.25 | 2.0E-5 | NA | |
99 | hsa-miR-30c-5p | CSNK1A1 | -0.98 | 5.0E-5 | -0.13 | 0.51313 | MirTarget; mirMAP; miRNATAP | -0.18 | 0.00097 | NA | |
100 | hsa-miR-30d-5p | CSNK1A1 | -0.55 | 0.01401 | -0.13 | 0.51313 | MirTarget; miRNATAP | -0.25 | 3.0E-5 | NA | |
101 | hsa-miR-320a | CSNK1A1 | 0.59 | 0.0119 | -0.13 | 0.51313 | mirMAP | -0.17 | 0.00251 | NA | |
102 | hsa-miR-320b | CSNK1A1 | 1.11 | 0.0005 | -0.13 | 0.51313 | mirMAP | -0.15 | 0.00043 | NA | |
103 | hsa-miR-335-3p | CSNK1A1 | 2.52 | 0 | -0.13 | 0.51313 | mirMAP | -0.16 | 0 | NA | |
104 | hsa-miR-501-3p | CSNK1A1 | 0.73 | 0.02704 | -0.13 | 0.51313 | TargetScan; miRNATAP | -0.16 | 0.00012 | NA | |
105 | hsa-miR-502-3p | CSNK1A1 | -0.16 | 0.55747 | -0.13 | 0.51313 | miRNATAP | -0.23 | 0 | NA | |
106 | hsa-miR-577 | CSNK1A1 | 0.91 | 0.22561 | -0.13 | 0.51313 | mirMAP | -0.1 | 0 | NA | |
107 | hsa-miR-592 | CSNK1A1 | 0.78 | 0.2045 | -0.13 | 0.51313 | MirTarget; PITA; miRNATAP | -0.14 | 0 | NA | |
108 | hsa-miR-652-3p | CSNK1A1 | 1.03 | 0.00034 | -0.13 | 0.51313 | miRNAWalker2 validate | -0.17 | 0.00038 | NA | |
109 | hsa-miR-664a-5p | CSNK1A1 | -0.13 | 0.62435 | -0.13 | 0.51313 | MirTarget | -0.22 | 1.0E-5 | NA | |
110 | hsa-miR-7-1-3p | CSNK1A1 | 0.71 | 0.04123 | -0.13 | 0.51313 | mirMAP | -0.26 | 0 | NA | |
111 | hsa-miR-30a-3p | CSNK1E | -1.73 | 0 | 0.53 | 0.0008 | miRNATAP | -0.11 | 0.00091 | NA | |
112 | hsa-miR-30c-5p | CSNK1E | -0.98 | 5.0E-5 | 0.53 | 0.0008 | miRNAWalker2 validate | -0.18 | 0.0001 | NA | |
113 | hsa-miR-30d-3p | CSNK1E | -0.55 | 0.04337 | 0.53 | 0.0008 | miRNATAP | -0.14 | 0.00107 | NA | |
114 | hsa-miR-125b-5p | CSNK2A1 | -0.51 | 0.13327 | 0.37 | 0.01132 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
115 | hsa-miR-143-3p | CSNK2A1 | -0.66 | 0.04832 | 0.37 | 0.01132 | MirTarget | -0.13 | 3.0E-5 | NA | |
116 | hsa-miR-126-5p | CSNK2A2 | 0.42 | 0.07532 | -0.24 | 0.1246 | mirMAP | -0.14 | 0.00403 | NA | |
117 | hsa-miR-181c-5p | CSNK2A2 | 0.34 | 0.11293 | -0.24 | 0.1246 | mirMAP | -0.21 | 0.00011 | NA | |
118 | hsa-miR-186-5p | CSNK2A2 | 0.15 | 0.43471 | -0.24 | 0.1246 | mirMAP | -0.22 | 0.00028 | NA | |
119 | hsa-miR-30d-3p | CSNK2A2 | -0.55 | 0.04337 | -0.24 | 0.1246 | mirMAP | -0.13 | 0.0026 | NA | |
120 | hsa-miR-32-5p | CSNK2A2 | 0.42 | 0.10646 | -0.24 | 0.1246 | mirMAP | -0.12 | 0.00502 | NA | |
121 | hsa-miR-320a | CSNK2A2 | 0.59 | 0.0119 | -0.24 | 0.1246 | mirMAP | -0.13 | 0.00787 | NA | |
122 | hsa-miR-342-3p | CTBP2 | 0.32 | 0.26915 | -0.01 | 0.94438 | MirTarget; PITA; miRanda; miRNATAP | -0.29 | 0 | NA | |
123 | hsa-miR-10a-5p | CTNNBIP1 | -0.47 | 0.1488 | -0.33 | 0.26613 | miRNATAP | -0.32 | 0 | NA | |
124 | hsa-miR-192-5p | CTNNBIP1 | 0.08 | 0.94106 | -0.33 | 0.26613 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.14 | 0 | NA | |
125 | hsa-miR-215-5p | CTNNBIP1 | 0.72 | 0.57378 | -0.33 | 0.26613 | miRNAWalker2 validate; MirTarget | -0.11 | 0 | NA | |
126 | hsa-miR-29b-3p | CTNNBIP1 | -0.23 | 0.36746 | -0.33 | 0.26613 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.27 | 0.0013 | NA | |
127 | hsa-miR-3614-5p | CTNNBIP1 | 1.1 | 0.00706 | -0.33 | 0.26613 | miRNATAP | -0.18 | 0.00047 | NA | |
128 | hsa-miR-625-5p | CTNNBIP1 | 0.54 | 0.2038 | -0.33 | 0.26613 | mirMAP | -0.26 | 0 | NA | |
129 | hsa-miR-21-5p | CXXC4 | 1.75 | 0 | -0.1 | 0.88463 | mirMAP | -0.67 | 0.00542 | NA | |
130 | hsa-miR-708-3p | CXXC4 | 0.62 | 0.27536 | -0.1 | 0.88463 | MirTarget | -0.25 | 0.00187 | NA | |
131 | hsa-miR-944 | CXXC4 | 3.33 | 0.01778 | -0.1 | 0.88463 | MirTarget; mirMAP | -0.14 | 0.00037 | NA | |
132 | hsa-let-7f-1-3p | DAAM1 | 1.29 | 0 | -0.57 | 0.03626 | MirTarget | -0.29 | 5.0E-5 | NA | |
133 | hsa-let-7g-3p | DAAM1 | 0.65 | 0.01031 | -0.57 | 0.03626 | MirTarget | -0.4 | 0 | NA | |
134 | hsa-miR-130b-3p | DAAM1 | 1.33 | 5.0E-5 | -0.57 | 0.03626 | MirTarget; miRNATAP | -0.24 | 4.0E-5 | NA | |
135 | hsa-miR-130b-5p | DAAM1 | 0.7 | 0.05101 | -0.57 | 0.03626 | MirTarget | -0.19 | 0.00035 | NA | |
136 | hsa-miR-140-5p | DAAM1 | 0.21 | 0.303 | -0.57 | 0.03626 | miRanda | -0.44 | 1.0E-5 | NA | |
137 | hsa-miR-142-3p | DAAM1 | 1.32 | 0.00015 | -0.57 | 0.03626 | miRanda | -0.2 | 0.00019 | NA | |
138 | hsa-miR-181a-5p | DAAM1 | 1.39 | 0 | -0.57 | 0.03626 | mirMAP | -0.32 | 6.0E-5 | NA | |
139 | hsa-miR-181b-5p | DAAM1 | 1.64 | 0 | -0.57 | 0.03626 | mirMAP | -0.27 | 2.0E-5 | NA | |
140 | hsa-miR-186-5p | DAAM1 | 0.15 | 0.43471 | -0.57 | 0.03626 | MirTarget; mirMAP | -0.49 | 0 | NA | |
141 | hsa-miR-194-5p | DAAM1 | -0.13 | 0.90607 | -0.57 | 0.03626 | miRNATAP | -0.11 | 0 | NA | |
142 | hsa-miR-19a-3p | DAAM1 | 1.27 | 0.00011 | -0.57 | 0.03626 | miRNATAP | -0.25 | 1.0E-5 | NA | |
143 | hsa-miR-19b-3p | DAAM1 | 0.76 | 0.00653 | -0.57 | 0.03626 | miRNATAP | -0.31 | 1.0E-5 | NA | |
144 | hsa-miR-29b-3p | DAAM1 | -0.23 | 0.36746 | -0.57 | 0.03626 | MirTarget; miRNATAP | -0.24 | 0.00212 | NA | |
145 | hsa-miR-301b-3p | DAAM1 | 1.1 | 0.07156 | -0.57 | 0.03626 | MirTarget | -0.12 | 0.00555 | NA | |
146 | hsa-miR-32-3p | DAAM1 | 0.58 | 0.11837 | -0.57 | 0.03626 | mirMAP | -0.28 | 0 | NA | |
147 | hsa-miR-32-5p | DAAM1 | 0.42 | 0.10646 | -0.57 | 0.03626 | miRNATAP | -0.38 | 0 | NA | |
148 | hsa-miR-320a | DAAM1 | 0.59 | 0.0119 | -0.57 | 0.03626 | miRanda | -0.31 | 0.00018 | NA | |
149 | hsa-miR-320b | DAAM1 | 1.11 | 0.0005 | -0.57 | 0.03626 | miRanda | -0.32 | 0 | NA | |
150 | hsa-miR-320c | DAAM1 | 0.46 | 0.24061 | -0.57 | 0.03626 | miRanda | -0.18 | 0.00149 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT SIGNALING PATHWAY | 72 | 351 | 1.073e-99 | 4.992e-96 |
2 | CANONICAL WNT SIGNALING PATHWAY | 36 | 95 | 3.701e-58 | 8.61e-55 |
3 | REGULATION OF WNT SIGNALING PATHWAY | 45 | 310 | 4.144e-52 | 6.428e-49 |
4 | NON CANONICAL WNT SIGNALING PATHWAY | 34 | 140 | 3.945e-47 | 4.589e-44 |
5 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 32 | 236 | 1.476e-35 | 1.373e-32 |
6 | NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 29 | 197 | 2.885e-33 | 2.237e-30 |
7 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 48 | 1021 | 2.993e-32 | 1.99e-29 |
8 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 60 | 1929 | 1.836e-31 | 1.068e-28 |
9 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 56 | 1672 | 1.279e-30 | 6.61e-28 |
10 | WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 17 | 39 | 7.978e-29 | 3.712e-26 |
11 | POSITIVE REGULATION OF GENE EXPRESSION | 54 | 1733 | 8.708e-28 | 3.684e-25 |
12 | REGULATION OF CELL DIFFERENTIATION | 50 | 1492 | 7.229e-27 | 2.587e-24 |
13 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 50 | 1492 | 7.229e-27 | 2.587e-24 |
14 | TISSUE DEVELOPMENT | 50 | 1518 | 1.595e-26 | 5.302e-24 |
15 | EPITHELIUM DEVELOPMENT | 41 | 945 | 8.089e-26 | 2.509e-23 |
16 | POSITIVE REGULATION OF CELL COMMUNICATION | 49 | 1532 | 2.363e-25 | 6.873e-23 |
17 | REGULATION OF PROTEIN MODIFICATION PROCESS | 51 | 1710 | 3.972e-25 | 1.087e-22 |
18 | REGULATION OF ORGAN MORPHOGENESIS | 25 | 242 | 1.015e-24 | 2.623e-22 |
19 | NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 22 | 162 | 1.752e-24 | 4.291e-22 |
20 | TISSUE MORPHOGENESIS | 32 | 533 | 3.3e-24 | 7.197e-22 |
21 | MORPHOGENESIS OF AN EPITHELIUM | 29 | 400 | 3.212e-24 | 7.197e-22 |
22 | TUBE MORPHOGENESIS | 27 | 323 | 3.403e-24 | 7.197e-22 |
23 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 51 | 1805 | 4.75e-24 | 9.61e-22 |
24 | NEGATIVE REGULATION OF CELL COMMUNICATION | 43 | 1192 | 5.62e-24 | 1.089e-21 |
25 | TUBE DEVELOPMENT | 32 | 552 | 9.695e-24 | 1.804e-21 |
26 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 45 | 1360 | 1.181e-23 | 2.113e-21 |
27 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 47 | 1618 | 2.012e-22 | 3.468e-20 |
28 | ORGAN MORPHOGENESIS | 36 | 841 | 2.606e-22 | 4.331e-20 |
29 | INTRACELLULAR SIGNAL TRANSDUCTION | 46 | 1572 | 5.067e-22 | 8.13e-20 |
30 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 40 | 1142 | 1.03e-21 | 1.597e-19 |
31 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 18 | 110 | 1.092e-21 | 1.64e-19 |
32 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 48 | 1791 | 1.82e-21 | 2.646e-19 |
33 | PATTERN SPECIFICATION PROCESS | 27 | 418 | 3.117e-21 | 4.395e-19 |
34 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 39 | 1135 | 7.663e-21 | 1.049e-18 |
35 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 47 | 1784 | 1.178e-20 | 1.565e-18 |
36 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 34 | 823 | 1.526e-20 | 1.973e-18 |
37 | EMBRYO DEVELOPMENT | 35 | 894 | 2.056e-20 | 2.585e-18 |
38 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 29 | 554 | 2.876e-20 | 3.521e-18 |
39 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 33 | 788 | 4.198e-20 | 4.884e-18 |
40 | CIRCULATORY SYSTEM DEVELOPMENT | 33 | 788 | 4.198e-20 | 4.884e-18 |
41 | NEURON DIFFERENTIATION | 34 | 874 | 1.001e-19 | 1.136e-17 |
42 | EMBRYONIC MORPHOGENESIS | 28 | 539 | 1.756e-19 | 1.945e-17 |
43 | REGIONALIZATION | 23 | 311 | 1.875e-19 | 2.029e-17 |
44 | NEUROGENESIS | 41 | 1402 | 2.082e-19 | 2.202e-17 |
45 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 36 | 1036 | 2.553e-19 | 2.583e-17 |
46 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 36 | 1036 | 2.553e-19 | 2.583e-17 |
47 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 35 | 1004 | 8.31e-19 | 8.227e-17 |
48 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 23 | 337 | 1.133e-18 | 1.098e-16 |
49 | REGULATION OF CELL CYCLE | 34 | 949 | 1.283e-18 | 1.218e-16 |
50 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 40 | 1395 | 1.341e-18 | 1.248e-16 |
51 | REGULATION OF EMBRYONIC DEVELOPMENT | 16 | 114 | 2.93e-18 | 2.673e-16 |
52 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 27 | 552 | 3.975e-18 | 3.557e-16 |
53 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 23 | 365 | 6.67e-18 | 5.856e-16 |
54 | REGULATION OF BINDING | 21 | 283 | 7.616e-18 | 6.563e-16 |
55 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 36 | 1152 | 7.845e-18 | 6.637e-16 |
56 | REGULATION OF CELL DEATH | 40 | 1472 | 8.829e-18 | 7.336e-16 |
57 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 42 | 1656 | 1.209e-17 | 9.87e-16 |
58 | POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 17 | 152 | 1.28e-17 | 1.027e-15 |
59 | BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY | 10 | 22 | 1.348e-17 | 1.063e-15 |
60 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 33 | 957 | 1.457e-17 | 1.13e-15 |
61 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 44 | 1848 | 1.599e-17 | 1.22e-15 |
62 | CELL FATE COMMITMENT | 19 | 227 | 3.413e-17 | 2.561e-15 |
63 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 18 | 194 | 3.926e-17 | 2.899e-15 |
64 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 30 | 801 | 6.377e-17 | 4.636e-15 |
65 | REGULATION OF PROTEIN LOCALIZATION | 32 | 950 | 9.918e-17 | 7.099e-15 |
66 | REGULATION OF CELL PROLIFERATION | 39 | 1496 | 1.068e-16 | 7.526e-15 |
67 | REGULATION OF CELLULAR RESPONSE TO STRESS | 28 | 691 | 1.137e-16 | 7.778e-15 |
68 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 21 | 323 | 1.127e-16 | 7.778e-15 |
69 | NEURAL TUBE DEVELOPMENT | 16 | 149 | 2.368e-16 | 1.597e-14 |
70 | REGULATION OF RESPONSE TO STRESS | 38 | 1468 | 3.812e-16 | 2.534e-14 |
71 | SENSORY ORGAN DEVELOPMENT | 24 | 493 | 4.16e-16 | 2.727e-14 |
72 | REGULATION OF CELL MORPHOGENESIS | 25 | 552 | 4.976e-16 | 3.216e-14 |
73 | CELL PROLIFERATION | 27 | 672 | 5.425e-16 | 3.458e-14 |
74 | PROTEIN PHOSPHORYLATION | 31 | 944 | 6.749e-16 | 4.195e-14 |
75 | DORSAL VENTRAL AXIS SPECIFICATION | 9 | 20 | 6.761e-16 | 4.195e-14 |
76 | CELL DEVELOPMENT | 37 | 1426 | 9.857e-16 | 6.035e-14 |
77 | CELLULAR RESPONSE TO RETINOIC ACID | 12 | 65 | 1.823e-15 | 1.101e-13 |
78 | REGULATION OF KINASE ACTIVITY | 28 | 776 | 2.17e-15 | 1.294e-13 |
79 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 15 | 142 | 2.764e-15 | 1.628e-13 |
80 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 21 | 381 | 3.094e-15 | 1.799e-13 |
81 | REGULATION OF TRANSFERASE ACTIVITY | 30 | 946 | 5.57e-15 | 3.2e-13 |
82 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 17 | 220 | 6.761e-15 | 3.837e-13 |
83 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 37 | 1518 | 7.113e-15 | 3.988e-13 |
84 | REGULATION OF PROTEIN TARGETING | 19 | 307 | 9.052e-15 | 5.014e-13 |
85 | CELL ACTIVATION | 24 | 568 | 9.677e-15 | 5.236e-13 |
86 | REGULATION OF CELLULAR LOCALIZATION | 34 | 1277 | 9.603e-15 | 5.236e-13 |
87 | REGULATION OF CELL DEVELOPMENT | 28 | 836 | 1.401e-14 | 7.495e-13 |
88 | HEART DEVELOPMENT | 22 | 466 | 1.533e-14 | 8.107e-13 |
89 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 22 | 470 | 1.826e-14 | 9.545e-13 |
90 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 15 | 162 | 2.005e-14 | 1.037e-12 |
91 | REGULATION OF CYTOPLASMIC TRANSPORT | 22 | 481 | 2.926e-14 | 1.496e-12 |
92 | POSITIVE REGULATION OF CELL DEATH | 24 | 605 | 3.857e-14 | 1.951e-12 |
93 | SOMITOGENESIS | 11 | 62 | 4.547e-14 | 2.275e-12 |
94 | SEGMENTATION | 12 | 89 | 9.6e-14 | 4.752e-12 |
95 | AXIS SPECIFICATION | 12 | 90 | 1.103e-13 | 5.4e-12 |
96 | REGULATION OF PROTEIN IMPORT | 15 | 183 | 1.225e-13 | 5.939e-12 |
97 | DORSAL VENTRAL PATTERN FORMATION | 12 | 91 | 1.264e-13 | 6.064e-12 |
98 | POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 13 | 119 | 1.396e-13 | 6.628e-12 |
99 | CELL CYCLE | 33 | 1316 | 1.434e-13 | 6.738e-12 |
100 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 30 | 1079 | 1.745e-13 | 8.117e-12 |
101 | CELL CYCLE PROCESS | 30 | 1081 | 1.83e-13 | 8.431e-12 |
102 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 40 | 1977 | 1.903e-13 | 8.595e-12 |
103 | NEURAL TUBE FORMATION | 12 | 94 | 1.887e-13 | 8.595e-12 |
104 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 35 | 1517 | 2.424e-13 | 1.084e-11 |
105 | REGULATION OF TRANSPORT | 38 | 1804 | 2.782e-13 | 1.233e-11 |
106 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 26 | 799 | 2.836e-13 | 1.245e-11 |
107 | REGULATION OF JNK CASCADE | 14 | 159 | 3.14e-13 | 1.366e-11 |
108 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 15 | 197 | 3.622e-13 | 1.561e-11 |
109 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 23 | 609 | 3.937e-13 | 1.681e-11 |
110 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 33 | 1381 | 5.481e-13 | 2.319e-11 |
111 | REGULATION OF CELL CYCLE PROCESS | 22 | 558 | 5.831e-13 | 2.444e-11 |
112 | REGULATION OF INTRACELLULAR TRANSPORT | 23 | 621 | 5.897e-13 | 2.45e-11 |
113 | SOMITE DEVELOPMENT | 11 | 78 | 6.455e-13 | 2.658e-11 |
114 | MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 13 | 134 | 6.589e-13 | 2.689e-11 |
115 | REGULATION OF PROTEIN BINDING | 14 | 168 | 6.725e-13 | 2.721e-11 |
116 | FC RECEPTOR SIGNALING PATHWAY | 15 | 206 | 6.958e-13 | 2.791e-11 |
117 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 28 | 983 | 7.466e-13 | 2.969e-11 |
118 | REGULATION OF PROTEIN CATABOLIC PROCESS | 19 | 393 | 7.59e-13 | 2.993e-11 |
119 | PHOSPHORYLATION | 31 | 1228 | 8.038e-13 | 3.143e-11 |
120 | MITOTIC CELL CYCLE | 25 | 766 | 8.255e-13 | 3.201e-11 |
121 | NEGATIVE REGULATION OF GENE EXPRESSION | 34 | 1493 | 8.579e-13 | 3.299e-11 |
122 | RESPONSE TO RETINOIC ACID | 12 | 107 | 9.214e-13 | 3.514e-11 |
123 | CELLULAR RESPONSE TO LIPID | 20 | 457 | 1.116e-12 | 4.223e-11 |
124 | POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 16 | 258 | 1.342e-12 | 5.034e-11 |
125 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 15 | 218 | 1.585e-12 | 5.899e-11 |
126 | REGULATION OF STEM CELL DIFFERENTIATION | 12 | 113 | 1.786e-12 | 6.596e-11 |
127 | BETA CATENIN TCF COMPLEX ASSEMBLY | 9 | 43 | 2.038e-12 | 7.466e-11 |
128 | REGULATION OF MAPK CASCADE | 23 | 660 | 2.063e-12 | 7.501e-11 |
129 | DOPAMINERGIC NEURON DIFFERENTIATION | 8 | 28 | 2.284e-12 | 8.24e-11 |
130 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 24 | 740 | 2.915e-12 | 1.043e-10 |
131 | RESPONSE TO LIPID | 26 | 888 | 3.127e-12 | 1.111e-10 |
132 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 12 | 121 | 4.074e-12 | 1.436e-10 |
133 | GASTRULATION | 13 | 155 | 4.311e-12 | 1.508e-10 |
134 | REGULATION OF IMMUNE SYSTEM PROCESS | 32 | 1403 | 4.709e-12 | 1.635e-10 |
135 | POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 16 | 282 | 5.194e-12 | 1.79e-10 |
136 | POSITIVE REGULATION OF CELL CYCLE | 17 | 332 | 5.491e-12 | 1.879e-10 |
137 | CELL DEATH | 27 | 1001 | 7.377e-12 | 2.505e-10 |
138 | TUBE FORMATION | 12 | 129 | 8.772e-12 | 2.958e-10 |
139 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 20 | 513 | 9.165e-12 | 3.068e-10 |
140 | REGULATION OF PROTEOLYSIS | 23 | 711 | 9.373e-12 | 3.115e-10 |
141 | REGULATION OF ORGANELLE ORGANIZATION | 29 | 1178 | 9.718e-12 | 3.207e-10 |
142 | REGULATION OF IMMUNE RESPONSE | 25 | 858 | 9.807e-12 | 3.214e-10 |
143 | RHYTHMIC PROCESS | 16 | 298 | 1.194e-11 | 3.887e-10 |
144 | EMBRYONIC ORGAN DEVELOPMENT | 18 | 406 | 1.363e-11 | 4.405e-10 |
145 | REGULATION OF CATABOLIC PROCESS | 23 | 731 | 1.639e-11 | 5.261e-10 |
146 | VASCULATURE DEVELOPMENT | 19 | 469 | 1.662e-11 | 5.296e-10 |
147 | POSITIVE REGULATION OF CELL DEVELOPMENT | 19 | 472 | 1.855e-11 | 5.871e-10 |
148 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 17 | 360 | 1.976e-11 | 6.213e-10 |
149 | CELLULAR RESPONSE TO ACID CHEMICAL | 13 | 175 | 2.021e-11 | 6.31e-10 |
150 | RESPONSE TO GROWTH FACTOR | 19 | 475 | 2.068e-11 | 6.416e-10 |
151 | POSITIVE REGULATION OF CELL PROLIFERATION | 24 | 814 | 2.143e-11 | 6.605e-10 |
152 | POSITIVE REGULATION OF KINASE ACTIVITY | 19 | 482 | 2.66e-11 | 8.142e-10 |
153 | REGULATION OF JUN KINASE ACTIVITY | 10 | 81 | 2.968e-11 | 9.026e-10 |
154 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 17 | 370 | 3.039e-11 | 9.182e-10 |
155 | REGULATION OF HYDROLASE ACTIVITY | 30 | 1327 | 3.259e-11 | 9.659e-10 |
156 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 12 | 144 | 3.239e-11 | 9.659e-10 |
157 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 21 | 616 | 3.225e-11 | 9.659e-10 |
158 | POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 14 | 228 | 4.247e-11 | 1.251e-09 |
159 | PEPTIDYL SERINE MODIFICATION | 12 | 148 | 4.474e-11 | 1.309e-09 |
160 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 23 | 771 | 4.758e-11 | 1.384e-09 |
161 | REGULATION OF GROWTH | 21 | 633 | 5.34e-11 | 1.543e-09 |
162 | NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 11 | 117 | 5.996e-11 | 1.722e-09 |
163 | HEAD DEVELOPMENT | 22 | 709 | 6.309e-11 | 1.79e-09 |
164 | DEVELOPMENTAL GROWTH | 16 | 333 | 6.275e-11 | 1.79e-09 |
165 | SENSORY ORGAN MORPHOGENESIS | 14 | 239 | 7.954e-11 | 2.236e-09 |
166 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 19 | 514 | 7.976e-11 | 2.236e-09 |
167 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 14 | 8.234e-11 | 2.294e-09 |
168 | MIDBRAIN DEVELOPMENT | 10 | 90 | 8.664e-11 | 2.4e-09 |
169 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 15 | 289 | 8.852e-11 | 2.423e-09 |
170 | NEGATIVE REGULATION OF CELL DEATH | 24 | 872 | 8.848e-11 | 2.423e-09 |
171 | NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT | 7 | 26 | 9.167e-11 | 2.494e-09 |
172 | IMMUNE SYSTEM PROCESS | 36 | 1984 | 1.084e-10 | 2.932e-09 |
173 | REGULATION OF CATENIN IMPORT INTO NUCLEUS | 7 | 27 | 1.232e-10 | 3.313e-09 |
174 | REPRODUCTIVE SYSTEM DEVELOPMENT | 17 | 408 | 1.393e-10 | 3.687e-09 |
175 | REGULATION OF MITOTIC CELL CYCLE | 18 | 468 | 1.395e-10 | 3.687e-09 |
176 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 67 | 1.381e-10 | 3.687e-09 |
177 | WOUND HEALING | 18 | 470 | 1.494e-10 | 3.929e-09 |
178 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 22 | 750 | 1.841e-10 | 4.786e-09 |
179 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 12 | 167 | 1.839e-10 | 4.786e-09 |
180 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 21 | 684 | 2.215e-10 | 5.725e-09 |
181 | HEART MORPHOGENESIS | 13 | 212 | 2.231e-10 | 5.736e-09 |
182 | DIGESTIVE TRACT MORPHOGENESIS | 8 | 48 | 2.526e-10 | 6.457e-09 |
183 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 11 | 135 | 2.842e-10 | 7.187e-09 |
184 | RESPONSE TO ENDOGENOUS STIMULUS | 30 | 1450 | 2.828e-10 | 7.187e-09 |
185 | REGULATION OF MAP KINASE ACTIVITY | 15 | 319 | 3.51e-10 | 8.827e-09 |
186 | RESPONSE TO WOUNDING | 19 | 563 | 3.706e-10 | 9.272e-09 |
187 | REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 12 | 181 | 4.673e-10 | 1.163e-08 |
188 | EYE DEVELOPMENT | 15 | 326 | 4.739e-10 | 1.173e-08 |
189 | INOSITOL PHOSPHATE MEDIATED SIGNALING | 6 | 18 | 4.997e-10 | 1.23e-08 |
190 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 23 | 876 | 5.841e-10 | 1.43e-08 |
191 | EMBRYONIC ORGAN MORPHOGENESIS | 14 | 279 | 6.096e-10 | 1.485e-08 |
192 | IMMUNE SYSTEM DEVELOPMENT | 19 | 582 | 6.45e-10 | 1.563e-08 |
193 | REGULATION OF CELL GROWTH | 16 | 391 | 6.618e-10 | 1.595e-08 |
194 | SKELETAL SYSTEM DEVELOPMENT | 17 | 455 | 7.416e-10 | 1.779e-08 |
195 | GLAND DEVELOPMENT | 16 | 395 | 7.669e-10 | 1.83e-08 |
196 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 10 | 112 | 7.73e-10 | 1.835e-08 |
197 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 14 | 285 | 8.042e-10 | 1.899e-08 |
198 | MESENCHYME DEVELOPMENT | 12 | 190 | 8.166e-10 | 1.909e-08 |
199 | STEM CELL DIFFERENTIATION | 12 | 190 | 8.166e-10 | 1.909e-08 |
200 | SINGLE ORGANISM CELL ADHESION | 17 | 459 | 8.471e-10 | 1.971e-08 |
201 | CONNECTIVE TISSUE DEVELOPMENT | 12 | 194 | 1.037e-09 | 2.4e-08 |
202 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 16 | 406 | 1.141e-09 | 2.628e-08 |
203 | EMBRYONIC PATTERN SPECIFICATION | 8 | 58 | 1.224e-09 | 2.806e-08 |
204 | GROWTH | 16 | 410 | 1.314e-09 | 2.997e-08 |
205 | STEM CELL PROLIFERATION | 8 | 60 | 1.619e-09 | 3.675e-08 |
206 | CELL CELL SIGNALING | 21 | 767 | 1.744e-09 | 3.92e-08 |
207 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 21 | 767 | 1.744e-09 | 3.92e-08 |
208 | POSITIVE REGULATION OF TRANSPORT | 23 | 936 | 2.088e-09 | 4.67e-08 |
209 | CELL CYCLE PHASE TRANSITION | 13 | 255 | 2.147e-09 | 4.78e-08 |
210 | REGULATION OF CELL ADHESION | 19 | 629 | 2.327e-09 | 5.156e-08 |
211 | LOCOMOTION | 25 | 1114 | 2.349e-09 | 5.18e-08 |
212 | POSITIVE REGULATION OF JUN KINASE ACTIVITY | 8 | 63 | 2.417e-09 | 5.304e-08 |
213 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 22 | 872 | 3.059e-09 | 6.683e-08 |
214 | POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 13 | 263 | 3.12e-09 | 6.729e-08 |
215 | APPENDAGE DEVELOPMENT | 11 | 169 | 3.124e-09 | 6.729e-08 |
216 | LIMB DEVELOPMENT | 11 | 169 | 3.124e-09 | 6.729e-08 |
217 | NEGATIVE REGULATION OF CELL GROWTH | 11 | 170 | 3.324e-09 | 7.12e-08 |
218 | NEGATIVE REGULATION OF CELL PROLIFERATION | 19 | 643 | 3.336e-09 | 7.12e-08 |
219 | RESPONSE TO ACID CHEMICAL | 14 | 319 | 3.443e-09 | 7.315e-08 |
220 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 18 | 573 | 3.501e-09 | 7.404e-08 |
221 | NEGATIVE REGULATION OF BINDING | 10 | 131 | 3.603e-09 | 7.552e-08 |
222 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 10 | 131 | 3.603e-09 | 7.552e-08 |
223 | PROTEIN COMPLEX SUBUNIT ORGANIZATION | 29 | 1527 | 4.324e-09 | 9.023e-08 |
224 | REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 13 | 274 | 5.11e-09 | 1.062e-07 |
225 | REGULATION OF OSSIFICATION | 11 | 178 | 5.391e-09 | 1.115e-07 |
226 | PEPTIDYL THREONINE MODIFICATION | 7 | 46 | 6.797e-09 | 1.399e-07 |
227 | POSITIVE REGULATION OF PROTEIN IMPORT | 9 | 104 | 7.457e-09 | 1.529e-07 |
228 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 18 | 602 | 7.548e-09 | 1.54e-07 |
229 | AXIS ELONGATION | 6 | 27 | 7.645e-09 | 1.553e-07 |
230 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 23 | 1008 | 8.471e-09 | 1.714e-07 |
231 | REGULATION OF FAT CELL DIFFERENTIATION | 9 | 106 | 8.83e-09 | 1.763e-07 |
232 | FAT CELL DIFFERENTIATION | 9 | 106 | 8.83e-09 | 1.763e-07 |
233 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 15 | 404 | 8.777e-09 | 1.763e-07 |
234 | POSITIVE REGULATION OF MAPK CASCADE | 16 | 470 | 9.191e-09 | 1.828e-07 |
235 | NEGATIVE REGULATION OF GROWTH | 12 | 236 | 9.522e-09 | 1.885e-07 |
236 | CONVERGENT EXTENSION | 5 | 14 | 1.012e-08 | 1.996e-07 |
237 | POSITIVE REGULATION OF GROWTH | 12 | 238 | 1.046e-08 | 2.054e-07 |
238 | RESPONSE TO ABIOTIC STIMULUS | 23 | 1024 | 1.137e-08 | 2.223e-07 |
239 | DIGESTIVE SYSTEM DEVELOPMENT | 10 | 148 | 1.174e-08 | 2.287e-07 |
240 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 7 | 50 | 1.245e-08 | 2.414e-07 |
241 | NEGATIVE REGULATION OF PROTEIN BINDING | 8 | 79 | 1.511e-08 | 2.917e-07 |
242 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 12 | 247 | 1.582e-08 | 3.043e-07 |
243 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 10 | 154 | 1.72e-08 | 3.294e-07 |
244 | POSITIVE REGULATION OF PROTEOLYSIS | 14 | 363 | 1.773e-08 | 3.381e-07 |
245 | MAMMARY GLAND EPITHELIUM DEVELOPMENT | 7 | 53 | 1.895e-08 | 3.599e-07 |
246 | RESPONSE TO DRUG | 15 | 431 | 2.077e-08 | 3.928e-07 |
247 | MAMMARY GLAND DEVELOPMENT | 9 | 117 | 2.109e-08 | 3.973e-07 |
248 | MUSCLE STRUCTURE DEVELOPMENT | 15 | 432 | 2.142e-08 | 4.018e-07 |
249 | PARAXIAL MESODERM DEVELOPMENT | 5 | 16 | 2.189e-08 | 4.091e-07 |
250 | LEUKOCYTE CELL CELL ADHESION | 12 | 255 | 2.254e-08 | 4.195e-07 |
251 | MESODERM DEVELOPMENT | 9 | 118 | 2.273e-08 | 4.213e-07 |
252 | SECOND MESSENGER MEDIATED SIGNALING | 10 | 160 | 2.479e-08 | 4.577e-07 |
253 | PALATE DEVELOPMENT | 8 | 85 | 2.71e-08 | 4.983e-07 |
254 | EMBRYONIC AXIS SPECIFICATION | 6 | 33 | 2.783e-08 | 5.098e-07 |
255 | EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 56 | 2.812e-08 | 5.13e-07 |
256 | CELLULAR COMPONENT MORPHOGENESIS | 21 | 900 | 2.854e-08 | 5.187e-07 |
257 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 34 | 3.364e-08 | 6.043e-07 |
258 | REGULATION OF CELL CYCLE PHASE TRANSITION | 13 | 321 | 3.352e-08 | 6.043e-07 |
259 | BRAIN MORPHOGENESIS | 6 | 34 | 3.364e-08 | 6.043e-07 |
260 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 23 | 1087 | 3.429e-08 | 6.136e-07 |
261 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 10 | 166 | 3.52e-08 | 6.275e-07 |
262 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 21 | 917 | 3.93e-08 | 6.98e-07 |
263 | CALCIUM MEDIATED SIGNALING | 8 | 90 | 4.263e-08 | 7.514e-07 |
264 | POST ANAL TAIL MORPHOGENESIS | 5 | 18 | 4.255e-08 | 7.514e-07 |
265 | REPRODUCTION | 25 | 1297 | 4.84e-08 | 8.498e-07 |
266 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 9 | 129 | 4.947e-08 | 8.653e-07 |
267 | EMBRYONIC DIGIT MORPHOGENESIS | 7 | 61 | 5.168e-08 | 9.006e-07 |
268 | REGULATION OF CELL SUBSTRATE ADHESION | 10 | 173 | 5.207e-08 | 9.04e-07 |
269 | REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 5 | 19 | 5.749e-08 | 9.944e-07 |
270 | BIOLOGICAL ADHESION | 22 | 1032 | 6.294e-08 | 1.085e-06 |
271 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 16 | 541 | 6.495e-08 | 1.107e-06 |
272 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 16 | 541 | 6.495e-08 | 1.107e-06 |
273 | REGULATION OF MUSCLE ADAPTATION | 7 | 63 | 6.493e-08 | 1.107e-06 |
274 | MESENCHYME MORPHOGENESIS | 6 | 38 | 6.779e-08 | 1.151e-06 |
275 | LYMPHOCYTE ACTIVATION | 13 | 342 | 7.03e-08 | 1.189e-06 |
276 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 20 | 867 | 7.716e-08 | 1.301e-06 |
277 | MACROMOLECULAR COMPLEX DISASSEMBLY | 10 | 182 | 8.399e-08 | 1.411e-06 |
278 | REGULATION OF DEVELOPMENTAL GROWTH | 12 | 289 | 8.902e-08 | 1.49e-06 |
279 | MESODERM MORPHOGENESIS | 7 | 66 | 9.013e-08 | 1.498e-06 |
280 | LENS DEVELOPMENT IN CAMERA TYPE EYE | 7 | 66 | 9.013e-08 | 1.498e-06 |
281 | LEUKOCYTE ACTIVATION | 14 | 414 | 9.083e-08 | 1.504e-06 |
282 | RESPONSE TO CYTOKINE | 18 | 714 | 1.012e-07 | 1.669e-06 |
283 | REGULATION OF CELL JUNCTION ASSEMBLY | 7 | 68 | 1.112e-07 | 1.828e-06 |
284 | REGULATION OF CIRCADIAN RHYTHM | 8 | 103 | 1.231e-07 | 2.002e-06 |
285 | CELLULAR RESPONSE TO STRESS | 27 | 1565 | 1.226e-07 | 2.002e-06 |
286 | STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 8 | 103 | 1.231e-07 | 2.002e-06 |
287 | SOMATIC STEM CELL DIVISION | 5 | 22 | 1.285e-07 | 2.08e-06 |
288 | UROGENITAL SYSTEM DEVELOPMENT | 12 | 299 | 1.288e-07 | 2.08e-06 |
289 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 8 | 104 | 1.327e-07 | 2.137e-06 |
290 | NEURAL PRECURSOR CELL PROLIFERATION | 7 | 70 | 1.362e-07 | 2.185e-06 |
291 | PROTEIN AUTOPHOSPHORYLATION | 10 | 192 | 1.387e-07 | 2.217e-06 |
292 | BLOOD VESSEL MORPHOGENESIS | 13 | 364 | 1.446e-07 | 2.305e-06 |
293 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 12 | 303 | 1.486e-07 | 2.361e-06 |
294 | CARTILAGE DEVELOPMENT | 9 | 147 | 1.526e-07 | 2.416e-06 |
295 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 20 | 905 | 1.543e-07 | 2.426e-06 |
296 | INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 8 | 106 | 1.539e-07 | 2.426e-06 |
297 | NEGATIVE REGULATION OF CELL CYCLE | 14 | 433 | 1.573e-07 | 2.464e-06 |
298 | REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 9 | 148 | 1.618e-07 | 2.526e-06 |
299 | IN UTERO EMBRYONIC DEVELOPMENT | 12 | 311 | 1.969e-07 | 3.063e-06 |
300 | FORMATION OF PRIMARY GERM LAYER | 8 | 110 | 2.052e-07 | 3.183e-06 |
301 | SKELETAL SYSTEM MORPHOGENESIS | 10 | 201 | 2.124e-07 | 3.284e-06 |
302 | REGULATION OF CELLULAR RESPONSE TO HEAT | 7 | 76 | 2.415e-07 | 3.721e-06 |
303 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 10 | 207 | 2.79e-07 | 4.285e-06 |
304 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 11 | 262 | 2.828e-07 | 4.328e-06 |
305 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 11 | 263 | 2.937e-07 | 4.481e-06 |
306 | POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 4 | 11 | 3.092e-07 | 4.702e-06 |
307 | CELL CELL ADHESION | 16 | 608 | 3.157e-07 | 4.786e-06 |
308 | POSITIVE REGULATION OF CATABOLIC PROCESS | 13 | 395 | 3.682e-07 | 5.562e-06 |
309 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 14 | 465 | 3.729e-07 | 5.615e-06 |
310 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 16 | 616 | 3.759e-07 | 5.643e-06 |
311 | PROTEASOMAL PROTEIN CATABOLIC PROCESS | 11 | 271 | 3.958e-07 | 5.922e-06 |
312 | NEURON PROJECTION DEVELOPMENT | 15 | 545 | 4.343e-07 | 6.477e-06 |
313 | REGULATION OF PROTEIN STABILITY | 10 | 221 | 5.099e-07 | 7.579e-06 |
314 | REGULATION OF NEURON DIFFERENTIATION | 15 | 554 | 5.341e-07 | 7.914e-06 |
315 | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 9 | 171 | 5.513e-07 | 8.144e-06 |
316 | STEM CELL DIVISION | 5 | 29 | 5.613e-07 | 8.265e-06 |
317 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 8 | 126 | 5.838e-07 | 8.57e-06 |
318 | HEMATOPOIETIC STEM CELL PROLIFERATION | 4 | 13 | 6.641e-07 | 9.627e-06 |
319 | REGULATION OF STEM CELL PROLIFERATION | 7 | 88 | 6.634e-07 | 9.627e-06 |
320 | REGULATION OF CELL FATE SPECIFICATION | 4 | 13 | 6.641e-07 | 9.627e-06 |
321 | REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 4 | 13 | 6.641e-07 | 9.627e-06 |
322 | OUTFLOW TRACT MORPHOGENESIS | 6 | 56 | 7.341e-07 | 1.061e-05 |
323 | NEGATIVE REGULATION OF PHOSPHORYLATION | 13 | 422 | 7.761e-07 | 1.118e-05 |
324 | FOREBRAIN DEVELOPMENT | 12 | 357 | 8.538e-07 | 1.225e-05 |
325 | ANGIOGENESIS | 11 | 293 | 8.556e-07 | 1.225e-05 |
326 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 18 | 829 | 9.006e-07 | 1.282e-05 |
327 | INNER EAR MORPHOGENESIS | 7 | 92 | 8.987e-07 | 1.282e-05 |
328 | MESENCHYMAL CELL DIFFERENTIATION | 8 | 134 | 9.331e-07 | 1.324e-05 |
329 | RESPONSE TO ALCOHOL | 12 | 362 | 9.88e-07 | 1.397e-05 |
330 | REGULATION OF APOPTOTIC SIGNALING PATHWAY | 12 | 363 | 1.017e-06 | 1.434e-05 |
331 | EYE MORPHOGENESIS | 8 | 136 | 1.044e-06 | 1.468e-05 |
332 | PEPTIDYL AMINO ACID MODIFICATION | 18 | 841 | 1.106e-06 | 1.548e-05 |
333 | REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 7 | 95 | 1.118e-06 | 1.548e-05 |
334 | CHONDROCYTE DIFFERENTIATION | 6 | 60 | 1.111e-06 | 1.548e-05 |
335 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 7 | 95 | 1.118e-06 | 1.548e-05 |
336 | REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 6 | 60 | 1.111e-06 | 1.548e-05 |
337 | CELL CYCLE G2 M PHASE TRANSITION | 8 | 138 | 1.166e-06 | 1.61e-05 |
338 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 11 | 303 | 1.188e-06 | 1.636e-05 |
339 | REGULATION OF MESODERM DEVELOPMENT | 4 | 15 | 1.257e-06 | 1.72e-05 |
340 | CELLULAR COMPONENT DISASSEMBLY | 14 | 515 | 1.257e-06 | 1.72e-05 |
341 | PROTEIN COMPLEX BIOGENESIS | 21 | 1132 | 1.282e-06 | 1.739e-05 |
342 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 5 | 34 | 1.286e-06 | 1.739e-05 |
343 | PROTEIN DESTABILIZATION | 5 | 34 | 1.286e-06 | 1.739e-05 |
344 | PROTEIN COMPLEX ASSEMBLY | 21 | 1132 | 1.282e-06 | 1.739e-05 |
345 | REGULATION OF SMOOTHENED SIGNALING PATHWAY | 6 | 62 | 1.352e-06 | 1.818e-05 |
346 | EMBRYONIC HEART TUBE MORPHOGENESIS | 6 | 62 | 1.352e-06 | 1.818e-05 |
347 | PLATELET ACTIVATION | 8 | 142 | 1.447e-06 | 1.94e-05 |
348 | POSITIVE REGULATION OF CELL ADHESION | 12 | 376 | 1.469e-06 | 1.964e-05 |
349 | REGULATION OF EPIDERMIS DEVELOPMENT | 6 | 63 | 1.488e-06 | 1.984e-05 |
350 | RESPONSE TO NITROGEN COMPOUND | 18 | 859 | 1.496e-06 | 1.989e-05 |
351 | NEGATIVE REGULATION OF KINASE ACTIVITY | 10 | 250 | 1.564e-06 | 2.074e-05 |
352 | NEURON DEVELOPMENT | 16 | 687 | 1.579e-06 | 2.087e-05 |
353 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 8 | 144 | 1.608e-06 | 2.119e-05 |
354 | CAMERA TYPE EYE MORPHOGENESIS | 7 | 101 | 1.692e-06 | 2.224e-05 |
355 | RESPIRATORY SYSTEM DEVELOPMENT | 9 | 197 | 1.795e-06 | 2.353e-05 |
356 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 7 | 103 | 1.931e-06 | 2.517e-05 |
357 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 7 | 103 | 1.931e-06 | 2.517e-05 |
358 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 9 | 199 | 1.952e-06 | 2.536e-05 |
359 | SOMATIC STEM CELL POPULATION MAINTENANCE | 6 | 66 | 1.962e-06 | 2.543e-05 |
360 | POSITIVE REGULATION OF CELL GROWTH | 8 | 148 | 1.976e-06 | 2.554e-05 |
361 | CELL DIVISION | 13 | 460 | 2.023e-06 | 2.607e-05 |
362 | REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 4 | 17 | 2.172e-06 | 2.769e-05 |
363 | REGULATION OF CHROMATIN BINDING | 4 | 17 | 2.172e-06 | 2.769e-05 |
364 | ESTABLISHMENT OF TISSUE POLARITY | 4 | 17 | 2.172e-06 | 2.769e-05 |
365 | REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 4 | 17 | 2.172e-06 | 2.769e-05 |
366 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 22 | 1275 | 2.275e-06 | 2.892e-05 |
367 | RESPONSE TO HORMONE | 18 | 893 | 2.587e-06 | 3.28e-05 |
368 | NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 5 | 39 | 2.602e-06 | 3.289e-05 |
369 | SEX DIFFERENTIATION | 10 | 266 | 2.728e-06 | 3.44e-05 |
370 | REGULATION OF CELL MATURATION | 4 | 18 | 2.781e-06 | 3.488e-05 |
371 | PERICARDIUM DEVELOPMENT | 4 | 18 | 2.781e-06 | 3.488e-05 |
372 | NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 7 | 109 | 2.825e-06 | 3.533e-05 |
373 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 8 | 156 | 2.929e-06 | 3.654e-05 |
374 | REGULATION OF MEIOTIC CELL CYCLE | 5 | 40 | 2.96e-06 | 3.673e-05 |
375 | POSITIVE REGULATION OF CELL MATRIX ADHESION | 5 | 40 | 2.96e-06 | 3.673e-05 |
376 | CELL PROJECTION ORGANIZATION | 18 | 902 | 2.977e-06 | 3.684e-05 |
377 | REGULATION OF CELL PROJECTION ORGANIZATION | 14 | 558 | 3.201e-06 | 3.951e-05 |
378 | REGULATION OF CELL DIVISION | 10 | 272 | 3.328e-06 | 4.097e-05 |
379 | EAR MORPHOGENESIS | 7 | 112 | 3.387e-06 | 4.159e-05 |
380 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 9 | 213 | 3.411e-06 | 4.177e-05 |
381 | POSITIVE REGULATION OF IMMUNE RESPONSE | 14 | 563 | 3.548e-06 | 4.333e-05 |
382 | EMBRYONIC HEART TUBE DEVELOPMENT | 6 | 73 | 3.56e-06 | 4.337e-05 |
383 | NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 5 | 43 | 4.272e-06 | 5.163e-05 |
384 | REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 5 | 43 | 4.272e-06 | 5.163e-05 |
385 | MORPHOGENESIS OF AN EPITHELIAL SHEET | 5 | 43 | 4.272e-06 | 5.163e-05 |
386 | CELL MOTILITY | 17 | 835 | 4.444e-06 | 5.343e-05 |
387 | LOCALIZATION OF CELL | 17 | 835 | 4.444e-06 | 5.343e-05 |
388 | EPITHELIAL CELL DIFFERENTIATION | 13 | 495 | 4.507e-06 | 5.405e-05 |
389 | SPECIFICATION OF SYMMETRY | 7 | 117 | 4.531e-06 | 5.42e-05 |
390 | POSITIVE REGULATION OF LOCOMOTION | 12 | 420 | 4.592e-06 | 5.479e-05 |
391 | LABYRINTHINE LAYER DEVELOPMENT | 5 | 44 | 4.798e-06 | 5.71e-05 |
392 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 6 | 77 | 4.869e-06 | 5.765e-05 |
393 | REGULATION OF BMP SIGNALING PATHWAY | 6 | 77 | 4.869e-06 | 5.765e-05 |
394 | REGULATION OF AXONOGENESIS | 8 | 168 | 5.078e-06 | 5.996e-05 |
395 | REGULATION OF CYTOSKELETON ORGANIZATION | 13 | 502 | 5.247e-06 | 6.18e-05 |
396 | POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION | 4 | 21 | 5.369e-06 | 6.292e-05 |
397 | COCHLEA MORPHOGENESIS | 4 | 21 | 5.369e-06 | 6.292e-05 |
398 | ACTIVATION OF IMMUNE RESPONSE | 12 | 427 | 5.432e-06 | 6.351e-05 |
399 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 7 | 122 | 5.979e-06 | 6.973e-05 |
400 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 9 | 229 | 6.148e-06 | 7.152e-05 |
401 | LEUKOCYTE DIFFERENTIATION | 10 | 292 | 6.231e-06 | 7.23e-05 |
402 | KIDNEY EPITHELIUM DEVELOPMENT | 7 | 125 | 7.02e-06 | 8.115e-05 |
403 | KIDNEY MORPHOGENESIS | 6 | 82 | 7.028e-06 | 8.115e-05 |
404 | OSTEOBLAST DIFFERENTIATION | 7 | 126 | 7.399e-06 | 8.5e-05 |
405 | RESPONSE TO UV | 7 | 126 | 7.399e-06 | 8.5e-05 |
406 | ANTERIOR POSTERIOR AXIS SPECIFICATION | 5 | 48 | 7.43e-06 | 8.515e-05 |
407 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 11 | 368 | 7.671e-06 | 8.77e-05 |
408 | REGULATION OF OSTEOBLAST PROLIFERATION | 4 | 23 | 7.874e-06 | 8.958e-05 |
409 | SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 4 | 23 | 7.874e-06 | 8.958e-05 |
410 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 6 | 84 | 8.084e-06 | 9.152e-05 |
411 | POSITIVE REGULATION OF OSSIFICATION | 6 | 84 | 8.084e-06 | 9.152e-05 |
412 | MUSCLE CELL DIFFERENTIATION | 9 | 237 | 8.11e-06 | 9.159e-05 |
413 | REGULATION OF PHOSPHATASE ACTIVITY | 7 | 128 | 8.207e-06 | 9.246e-05 |
414 | REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 50 | 9.112e-06 | 0.0001024 |
415 | POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 4 | 24 | 9.408e-06 | 0.0001052 |
416 | REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY | 4 | 24 | 9.408e-06 | 0.0001052 |
417 | MACROMOLECULAR COMPLEX ASSEMBLY | 22 | 1398 | 9.974e-06 | 0.0001113 |
418 | POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 5 | 51 | 1.006e-05 | 0.0001114 |
419 | POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 5 | 51 | 1.006e-05 | 0.0001114 |
420 | MAINTENANCE OF CELL NUMBER | 7 | 132 | 1.004e-05 | 0.0001114 |
421 | RESPONSE TO OXYGEN LEVELS | 10 | 311 | 1.081e-05 | 0.0001192 |
422 | HEMOSTASIS | 10 | 311 | 1.081e-05 | 0.0001192 |
423 | POSITIVE REGULATION OF INNATE IMMUNE RESPONSE | 9 | 246 | 1.094e-05 | 0.0001203 |
424 | NEGATIVE REGULATION OF TRANSPORT | 12 | 458 | 1.1e-05 | 0.0001208 |
425 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 10 | 312 | 1.111e-05 | 0.0001217 |
426 | LENS FIBER CELL DIFFERENTIATION | 4 | 25 | 1.115e-05 | 0.0001218 |
427 | EPITHELIAL CELL PROLIFERATION | 6 | 89 | 1.13e-05 | 0.0001231 |
428 | REGULATION OF CELL MATRIX ADHESION | 6 | 90 | 1.205e-05 | 0.0001307 |
429 | MESONEPHROS DEVELOPMENT | 6 | 90 | 1.205e-05 | 0.0001307 |
430 | TAXIS | 12 | 464 | 1.253e-05 | 0.000135 |
431 | PROTEIN DEPHOSPHORYLATION | 8 | 190 | 1.251e-05 | 0.000135 |
432 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 8 | 190 | 1.251e-05 | 0.000135 |
433 | CELLULAR RESPONSE TO RADIATION | 7 | 137 | 1.281e-05 | 0.0001376 |
434 | OSSIFICATION | 9 | 251 | 1.284e-05 | 0.0001377 |
435 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 8 | 191 | 1.3e-05 | 0.000139 |
436 | REGULATION OF CELL FATE COMMITMENT | 4 | 26 | 1.312e-05 | 0.00014 |
437 | PLACENTA DEVELOPMENT | 7 | 138 | 1.343e-05 | 0.000143 |
438 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 15 | 724 | 1.397e-05 | 0.0001484 |
439 | MITOTIC CELL CYCLE CHECKPOINT | 7 | 139 | 1.408e-05 | 0.0001492 |
440 | REGULATION OF PEPTIDE TRANSPORT | 9 | 256 | 1.502e-05 | 0.0001589 |
441 | REGULATION OF MUSCLE SYSTEM PROCESS | 8 | 195 | 1.51e-05 | 0.0001594 |
442 | DEVELOPMENTAL INDUCTION | 4 | 27 | 1.534e-05 | 0.0001611 |
443 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 4 | 27 | 1.534e-05 | 0.0001611 |
444 | SYSTEM PROCESS | 25 | 1785 | 1.672e-05 | 0.0001752 |
445 | RESPONSE TO INORGANIC SUBSTANCE | 12 | 479 | 1.718e-05 | 0.0001797 |
446 | NEURON PROJECTION MORPHOGENESIS | 11 | 402 | 1.751e-05 | 0.0001826 |
447 | CARDIAC CHAMBER DEVELOPMENT | 7 | 144 | 1.771e-05 | 0.0001842 |
448 | REGULATION OF CYTOKINE PRODUCTION | 13 | 563 | 1.779e-05 | 0.0001842 |
449 | GASTRULATION WITH MOUTH FORMING SECOND | 4 | 28 | 1.781e-05 | 0.0001842 |
450 | MORPHOGENESIS OF A POLARIZED EPITHELIUM | 4 | 28 | 1.781e-05 | 0.0001842 |
451 | NEGATIVE REGULATION OF LOCOMOTION | 9 | 263 | 1.861e-05 | 0.000192 |
452 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 9 | 264 | 1.917e-05 | 0.0001974 |
453 | RESPONSE TO METAL ION | 10 | 333 | 1.95e-05 | 0.0002003 |
454 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 11 | 408 | 2.007e-05 | 0.0002057 |
455 | POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 6 | 99 | 2.081e-05 | 0.0002128 |
456 | ACTIVATION OF INNATE IMMUNE RESPONSE | 8 | 204 | 2.091e-05 | 0.0002134 |
457 | NEURON PROJECTION GUIDANCE | 8 | 205 | 2.166e-05 | 0.0002206 |
458 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 6 | 100 | 2.203e-05 | 0.0002239 |
459 | RESPONSE TO RADIATION | 11 | 413 | 2.245e-05 | 0.0002276 |
460 | RESPONSE TO EXTERNAL STIMULUS | 25 | 1821 | 2.346e-05 | 0.0002373 |
461 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 5 | 61 | 2.435e-05 | 0.0002458 |
462 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 6 | 102 | 2.466e-05 | 0.0002484 |
463 | NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 8 | 209 | 2.488e-05 | 0.0002495 |
464 | LYMPHOCYTE DIFFERENTIATION | 8 | 209 | 2.488e-05 | 0.0002495 |
465 | PALLIUM DEVELOPMENT | 7 | 153 | 2.62e-05 | 0.0002622 |
466 | COVALENT CHROMATIN MODIFICATION | 10 | 345 | 2.638e-05 | 0.0002634 |
467 | SKIN DEVELOPMENT | 8 | 211 | 2.664e-05 | 0.0002654 |
468 | REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 4 | 31 | 2.702e-05 | 0.0002686 |
469 | AMEBOIDAL TYPE CELL MIGRATION | 7 | 154 | 2.732e-05 | 0.0002711 |
470 | CARDIAC CHAMBER MORPHOGENESIS | 6 | 104 | 2.754e-05 | 0.0002726 |
471 | POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 3 | 11 | 2.804e-05 | 0.000277 |
472 | REGULATION OF CHROMOSOME ORGANIZATION | 9 | 278 | 2.879e-05 | 0.0002838 |
473 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 10 | 351 | 3.054e-05 | 0.0003005 |
474 | NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 5 | 64 | 3.079e-05 | 0.000301 |
475 | REGULATION OF ORGAN FORMATION | 4 | 32 | 3.075e-05 | 0.000301 |
476 | PATTERNING OF BLOOD VESSELS | 4 | 32 | 3.075e-05 | 0.000301 |
477 | REGULATION OF DEPHOSPHORYLATION | 7 | 158 | 3.221e-05 | 0.0003142 |
478 | NEGATIVE REGULATION OF AXONOGENESIS | 5 | 65 | 3.321e-05 | 0.0003233 |
479 | REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 6 | 108 | 3.41e-05 | 0.0003312 |
480 | POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 4 | 33 | 3.484e-05 | 0.0003377 |
481 | CELLULAR RESPONSE TO UV | 5 | 66 | 3.577e-05 | 0.0003453 |
482 | FOREBRAIN GENERATION OF NEURONS | 5 | 66 | 3.577e-05 | 0.0003453 |
483 | POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 3 | 12 | 3.723e-05 | 0.0003557 |
484 | POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS | 3 | 12 | 3.723e-05 | 0.0003557 |
485 | MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 3 | 12 | 3.723e-05 | 0.0003557 |
486 | REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 3 | 12 | 3.723e-05 | 0.0003557 |
487 | LENS FIBER CELL DEVELOPMENT | 3 | 12 | 3.723e-05 | 0.0003557 |
488 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 11 | 437 | 3.761e-05 | 0.0003579 |
489 | G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 19 | 1193 | 3.755e-05 | 0.0003579 |
490 | APOPTOTIC SIGNALING PATHWAY | 9 | 289 | 3.897e-05 | 0.0003701 |
491 | NEURAL TUBE PATTERNING | 4 | 34 | 3.931e-05 | 0.0003725 |
492 | REGULATION OF SECRETION | 14 | 699 | 4e-05 | 0.0003783 |
493 | REGULATION OF GASTRULATION | 4 | 35 | 4.419e-05 | 0.0004171 |
494 | POSITIVE REGULATION OF AXONOGENESIS | 5 | 69 | 4.438e-05 | 0.0004172 |
495 | SYNAPSE ASSEMBLY | 5 | 69 | 4.438e-05 | 0.0004172 |
496 | POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 7 | 167 | 4.587e-05 | 0.0004303 |
497 | TELENCEPHALON DEVELOPMENT | 8 | 228 | 4.621e-05 | 0.0004326 |
498 | RESPONSE TO CARBOHYDRATE | 7 | 168 | 4.764e-05 | 0.0004443 |
499 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 10 | 370 | 4.765e-05 | 0.0004443 |
500 | REGULATION OF SKELETAL MUSCLE ADAPTATION | 3 | 13 | 4.82e-05 | 0.0004485 |
501 | RESPONSE TO CALCIUM ION | 6 | 115 | 4.856e-05 | 0.000451 |
502 | CHROMOSOME ORGANIZATION | 17 | 1009 | 5.066e-05 | 0.0004696 |
503 | NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 5 | 71 | 5.095e-05 | 0.0004714 |
504 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 8 | 232 | 5.224e-05 | 0.0004813 |
505 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 8 | 232 | 5.224e-05 | 0.0004813 |
506 | MODULATION OF SYNAPTIC TRANSMISSION | 9 | 301 | 5.34e-05 | 0.0004911 |
507 | REGULATION OF VASCULATURE DEVELOPMENT | 8 | 233 | 5.385e-05 | 0.0004942 |
508 | CHROMATIN MODIFICATION | 12 | 539 | 5.423e-05 | 0.0004967 |
509 | REGULATION OF MUSCLE HYPERTROPHY | 4 | 37 | 5.525e-05 | 0.0005051 |
510 | STRIATED MUSCLE CELL DIFFERENTIATION | 7 | 173 | 5.737e-05 | 0.0005234 |
511 | NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 5 | 73 | 5.826e-05 | 0.0005294 |
512 | POSITIVE REGULATION OF PROTEIN BINDING | 5 | 73 | 5.826e-05 | 0.0005294 |
513 | CELL MIGRATION INVOLVED IN GASTRULATION | 3 | 14 | 6.109e-05 | 0.000553 |
514 | REGULATION OF MONOCYTE DIFFERENTIATION | 3 | 14 | 6.109e-05 | 0.000553 |
515 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 6 | 121 | 6.454e-05 | 0.0005831 |
516 | NEURAL CREST CELL DIFFERENTIATION | 5 | 75 | 6.635e-05 | 0.0005983 |
517 | COCHLEA DEVELOPMENT | 4 | 39 | 6.822e-05 | 0.000614 |
518 | POSITIVE REGULATION OF MITOTIC CELL CYCLE | 6 | 123 | 7.071e-05 | 0.0006339 |
519 | T CELL DIFFERENTIATION | 6 | 123 | 7.071e-05 | 0.0006339 |
520 | NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 4 | 40 | 7.547e-05 | 0.0006753 |
521 | NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 3 | 15 | 7.605e-05 | 0.0006792 |
522 | NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 4 | 41 | 8.326e-05 | 0.0007422 |
523 | REGULATION OF HORMONE LEVELS | 11 | 478 | 8.41e-05 | 0.0007482 |
524 | POSITIVE REGULATION OF BINDING | 6 | 127 | 8.446e-05 | 0.00075 |
525 | REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 6 | 128 | 8.821e-05 | 0.0007803 |
526 | MUSCLE CELL DEVELOPMENT | 6 | 128 | 8.821e-05 | 0.0007803 |
527 | COGNITION | 8 | 251 | 9.06e-05 | 0.0007984 |
528 | EPITHELIAL CELL DEVELOPMENT | 7 | 186 | 9.05e-05 | 0.0007984 |
529 | NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 4 | 42 | 9.163e-05 | 0.000806 |
530 | REGULATION OF REPRODUCTIVE PROCESS | 6 | 129 | 9.209e-05 | 0.0008085 |
531 | APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 3 | 16 | 9.321e-05 | 0.0008153 |
532 | CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 3 | 16 | 9.321e-05 | 0.0008153 |
533 | CHROMATIN ORGANIZATION | 13 | 663 | 9.51e-05 | 0.0008302 |
534 | REGULATION OF FIBROBLAST PROLIFERATION | 5 | 81 | 9.588e-05 | 0.0008354 |
535 | PROTEIN STABILIZATION | 6 | 131 | 0.0001003 | 0.000872 |
536 | JNK CASCADE | 5 | 82 | 0.0001016 | 0.0008824 |
537 | NEGATIVE REGULATION OF PROTEOLYSIS | 9 | 329 | 0.0001054 | 0.0009132 |
538 | EMBRYONIC PLACENTA DEVELOPMENT | 5 | 83 | 0.0001077 | 0.0009313 |
539 | POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 7 | 192 | 0.0001103 | 0.0009525 |
540 | CELL CYCLE CHECKPOINT | 7 | 194 | 0.0001177 | 0.001014 |
541 | NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 6 | 135 | 0.0001183 | 0.001018 |
542 | CARDIAC SEPTUM DEVELOPMENT | 5 | 85 | 0.0001206 | 0.001035 |
543 | ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 7 | 195 | 0.0001215 | 0.001039 |
544 | EAR DEVELOPMENT | 7 | 195 | 0.0001215 | 0.001039 |
545 | REGULATION OF HORMONE SECRETION | 8 | 262 | 0.0001219 | 0.001041 |
546 | POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY | 7 | 197 | 0.0001294 | 0.001103 |
547 | UTERUS DEVELOPMENT | 3 | 18 | 0.0001347 | 0.001144 |
548 | SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 3 | 18 | 0.0001347 | 0.001144 |
549 | REGULATION OF DNA METABOLIC PROCESS | 9 | 340 | 0.0001351 | 0.001145 |
550 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 11 | 505 | 0.0001364 | 0.001154 |
551 | REGULATION OF BODY FLUID LEVELS | 11 | 506 | 0.0001388 | 0.001172 |
552 | NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 5 | 88 | 0.0001421 | 0.001198 |
553 | REGULATION OF SYNAPTIC PLASTICITY | 6 | 140 | 0.0001445 | 0.001215 |
554 | SYNAPTIC SIGNALING | 10 | 424 | 0.0001467 | 0.001232 |
555 | ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 6 | 141 | 0.0001502 | 0.001259 |
556 | POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 4 | 48 | 0.0001552 | 0.001299 |
557 | NEGATIVE REGULATION OF CATABOLIC PROCESS | 7 | 203 | 0.0001558 | 0.001302 |
558 | ENDOTHELIUM DEVELOPMENT | 5 | 90 | 0.000158 | 0.001317 |
559 | POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 3 | 19 | 0.0001593 | 0.001326 |
560 | CELLULAR RESPONSE TO CYTOKINE STIMULUS | 12 | 606 | 0.0001636 | 0.00136 |
561 | PROTEIN LOCALIZATION | 23 | 1805 | 0.0001646 | 0.001365 |
562 | CELLULAR RESPONSE TO LIGHT STIMULUS | 5 | 91 | 0.0001664 | 0.001378 |
563 | CARDIAC SEPTUM MORPHOGENESIS | 4 | 49 | 0.0001683 | 0.001391 |
564 | HOMEOSTATIC PROCESS | 19 | 1337 | 0.0001698 | 0.001401 |
565 | SYNAPSE ORGANIZATION | 6 | 145 | 0.000175 | 0.001438 |
566 | NEGATIVE REGULATION OF MAPK CASCADE | 6 | 145 | 0.000175 | 0.001438 |
567 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 7 | 207 | 0.0001757 | 0.001442 |
568 | MUSCLE ORGAN DEVELOPMENT | 8 | 277 | 0.0001785 | 0.001462 |
569 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 6 | 146 | 0.0001816 | 0.001484 |
570 | POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 4 | 50 | 0.0001821 | 0.001484 |
571 | RHO PROTEIN SIGNAL TRANSDUCTION | 4 | 50 | 0.0001821 | 0.001484 |
572 | REGULATION OF DNA BINDING | 5 | 93 | 0.0001843 | 0.001499 |
573 | TONGUE DEVELOPMENT | 3 | 20 | 0.0001867 | 0.001505 |
574 | TRACHEA DEVELOPMENT | 3 | 20 | 0.0001867 | 0.001505 |
575 | POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 3 | 20 | 0.0001867 | 0.001505 |
576 | REGULATION OF PEPTIDE SECRETION | 7 | 209 | 0.0001864 | 0.001505 |
577 | BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 3 | 20 | 0.0001867 | 0.001505 |
578 | REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 6 | 147 | 0.0001885 | 0.001517 |
579 | RESPONSE TO LIGHT STIMULUS | 8 | 280 | 0.0001921 | 0.001544 |
580 | REGULATION OF INNATE IMMUNE RESPONSE | 9 | 357 | 0.0001945 | 0.001561 |
581 | MALE SEX DIFFERENTIATION | 6 | 148 | 0.0001956 | 0.001566 |
582 | NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 5 | 95 | 0.0002036 | 0.001628 |
583 | APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 3 | 21 | 0.0002169 | 0.001731 |
584 | DEPHOSPHORYLATION | 8 | 286 | 0.0002218 | 0.001767 |
585 | POSITIVE REGULATION OF DEFENSE RESPONSE | 9 | 364 | 0.0002246 | 0.001787 |
586 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 6 | 152 | 0.000226 | 0.001794 |
587 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 4 | 53 | 0.0002285 | 0.001805 |
588 | POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 4 | 53 | 0.0002285 | 0.001805 |
589 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 7 | 216 | 0.0002281 | 0.001805 |
590 | POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 5 | 98 | 0.0002355 | 0.001857 |
591 | REGULATION OF MITOCHONDRION ORGANIZATION | 7 | 218 | 0.0002412 | 0.001899 |
592 | CELL PART MORPHOGENESIS | 12 | 633 | 0.0002443 | 0.00192 |
593 | CEREBRAL CORTEX NEURON DIFFERENTIATION | 3 | 22 | 0.0002501 | 0.001946 |
594 | MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION | 3 | 22 | 0.0002501 | 0.001946 |
595 | POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 3 | 22 | 0.0002501 | 0.001946 |
596 | POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY | 3 | 22 | 0.0002501 | 0.001946 |
597 | REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 3 | 22 | 0.0002501 | 0.001946 |
598 | EMBRYONIC PLACENTA MORPHOGENESIS | 3 | 22 | 0.0002501 | 0.001946 |
599 | REGULATION OF EXTENT OF CELL GROWTH | 5 | 101 | 0.000271 | 0.002105 |
600 | SMAD PROTEIN SIGNAL TRANSDUCTION | 4 | 56 | 0.0002829 | 0.002191 |
601 | INOSITOL PHOSPHATE METABOLIC PROCESS | 4 | 56 | 0.0002829 | 0.002191 |
602 | NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 3 | 23 | 0.0002864 | 0.002214 |
603 | CELLULAR RESPONSE TO HORMONE STIMULUS | 11 | 552 | 0.0002938 | 0.002267 |
604 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 5 | 103 | 0.0002969 | 0.002287 |
605 | MYOTUBE DIFFERENTIATION | 4 | 57 | 0.000303 | 0.00233 |
606 | REGENERATION | 6 | 161 | 0.000308 | 0.002365 |
607 | CEREBRAL CORTEX DEVELOPMENT | 5 | 105 | 0.0003245 | 0.002488 |
608 | POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 3 | 24 | 0.000326 | 0.002495 |
609 | REGULATION OF NUCLEAR DIVISION | 6 | 163 | 0.0003291 | 0.00251 |
610 | CELLULAR RESPONSE TO BIOTIC STIMULUS | 6 | 163 | 0.0003291 | 0.00251 |
611 | VASCULOGENESIS | 4 | 59 | 0.0003461 | 0.002635 |
612 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 8 | 306 | 0.0003493 | 0.002656 |
613 | REGULATION OF EPITHELIAL CELL MIGRATION | 6 | 166 | 0.0003628 | 0.002754 |
614 | REGULATION OF PROTEIN SECRETION | 9 | 389 | 0.0003657 | 0.002772 |
615 | NEGATIVE REGULATION OF CELL DIVISION | 4 | 60 | 0.0003692 | 0.00278 |
616 | SPINDLE CHECKPOINT | 3 | 25 | 0.0003689 | 0.00278 |
617 | NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 3 | 25 | 0.0003689 | 0.00278 |
618 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 4 | 60 | 0.0003692 | 0.00278 |
619 | REGULATION OF PEPTIDASE ACTIVITY | 9 | 392 | 0.0003868 | 0.002907 |
620 | CHEMICAL HOMEOSTASIS | 14 | 874 | 0.0004115 | 0.003088 |
621 | DEVELOPMENTAL PROGRAMMED CELL DEATH | 3 | 26 | 0.0004153 | 0.003112 |
622 | CELL CYCLE G1 S PHASE TRANSITION | 5 | 111 | 0.0004194 | 0.003132 |
623 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 5 | 111 | 0.0004194 | 0.003132 |
624 | REGULATION OF GTPASE ACTIVITY | 12 | 673 | 0.0004248 | 0.003167 |
625 | REGULATION OF CELL SIZE | 6 | 172 | 0.0004382 | 0.003262 |
626 | PROTEIN CATABOLIC PROCESS | 11 | 579 | 0.0004396 | 0.003268 |
627 | REGULATION OF CARTILAGE DEVELOPMENT | 4 | 63 | 0.0004452 | 0.003304 |
628 | SKELETAL MUSCLE TISSUE REGENERATION | 3 | 27 | 0.0004653 | 0.003431 |
629 | REGULATION OF MICROTUBULE BASED PROCESS | 7 | 243 | 0.0004644 | 0.003431 |
630 | NEGATIVE REGULATION OF AXON GUIDANCE | 3 | 27 | 0.0004653 | 0.003431 |
631 | RESPONSE TO LITHIUM ION | 3 | 27 | 0.0004653 | 0.003431 |
632 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 5 | 114 | 0.000474 | 0.003489 |
633 | POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 6 | 175 | 0.0004803 | 0.00353 |
634 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 5 | 115 | 0.0004933 | 0.003603 |
635 | RESPONSE TO INTERLEUKIN 1 | 5 | 115 | 0.0004933 | 0.003603 |
636 | CELLULAR RESPONSE TO ALCOHOL | 5 | 115 | 0.0004933 | 0.003603 |
637 | NEPHRON DEVELOPMENT | 5 | 115 | 0.0004933 | 0.003603 |
638 | MITOCHONDRIAL TRANSPORT | 6 | 177 | 0.00051 | 0.00372 |
639 | VENTRICULAR SEPTUM MORPHOGENESIS | 3 | 28 | 0.000519 | 0.00375 |
640 | RESPONSE TO STEROID HORMONE | 10 | 497 | 0.0005181 | 0.00375 |
641 | PLACENTA BLOOD VESSEL DEVELOPMENT | 3 | 28 | 0.000519 | 0.00375 |
642 | NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 3 | 28 | 0.000519 | 0.00375 |
643 | NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 3 | 28 | 0.000519 | 0.00375 |
644 | MAMMARY GLAND DUCT MORPHOGENESIS | 3 | 28 | 0.000519 | 0.00375 |
645 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 12 | 689 | 0.0005235 | 0.003776 |
646 | NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT | 5 | 117 | 0.0005337 | 0.003844 |
647 | REGULATION OF CHEMOTAXIS | 6 | 180 | 0.0005573 | 0.004008 |
648 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 4 | 67 | 0.000563 | 0.004024 |
649 | REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 4 | 67 | 0.000563 | 0.004024 |
650 | CELLULAR RESPONSE TO DRUG | 4 | 67 | 0.000563 | 0.004024 |
651 | REGULATION OF SISTER CHROMATID SEGREGATION | 4 | 67 | 0.000563 | 0.004024 |
652 | NEUROBLAST PROLIFERATION | 3 | 29 | 0.0005765 | 0.004114 |
653 | RESPONSE TO KETONE | 6 | 182 | 0.0005906 | 0.004209 |
654 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 4 | 68 | 0.0005956 | 0.004231 |
655 | POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 4 | 68 | 0.0005956 | 0.004231 |
656 | REGULATION OF DENDRITE DEVELOPMENT | 5 | 120 | 0.000599 | 0.004249 |
657 | REGULATION OF SYSTEM PROCESS | 10 | 507 | 0.0006045 | 0.004281 |
658 | REGULATION OF MYELOID CELL DIFFERENTIATION | 6 | 183 | 0.0006079 | 0.004299 |
659 | NEGATIVE REGULATION OF OSSIFICATION | 4 | 69 | 0.0006295 | 0.004445 |
660 | POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 3 | 30 | 0.000638 | 0.004477 |
661 | NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 3 | 30 | 0.000638 | 0.004477 |
662 | RESPONSE TO X RAY | 3 | 30 | 0.000638 | 0.004477 |
663 | MYOTUBE CELL DEVELOPMENT | 3 | 30 | 0.000638 | 0.004477 |
664 | CELLULAR RESPONSE TO INTERFERON GAMMA | 5 | 122 | 0.0006458 | 0.004525 |
665 | MUSCLE ORGAN MORPHOGENESIS | 4 | 70 | 0.0006648 | 0.004637 |
666 | INTERFERON GAMMA MEDIATED SIGNALING PATHWAY | 4 | 70 | 0.0006648 | 0.004637 |
667 | REGULATION OF MEMBRANE PERMEABILITY | 4 | 70 | 0.0006648 | 0.004637 |
668 | CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 6 | 188 | 0.0007001 | 0.004864 |
669 | SKIN EPIDERMIS DEVELOPMENT | 4 | 71 | 0.0007014 | 0.004864 |
670 | ENDODERM DEVELOPMENT | 4 | 71 | 0.0007014 | 0.004864 |
671 | CELL FATE SPECIFICATION | 4 | 71 | 0.0007014 | 0.004864 |
672 | ENDOTHELIAL CELL DIFFERENTIATION | 4 | 72 | 0.0007395 | 0.00512 |
673 | EMBRYONIC FORELIMB MORPHOGENESIS | 3 | 32 | 0.000773 | 0.005321 |
674 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 3 | 32 | 0.000773 | 0.005321 |
675 | POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 3 | 32 | 0.000773 | 0.005321 |
676 | ADIPOSE TISSUE DEVELOPMENT | 3 | 32 | 0.000773 | 0.005321 |
677 | PANCREAS DEVELOPMENT | 4 | 73 | 0.0007789 | 0.005354 |
678 | HEPATICOBILIARY SYSTEM DEVELOPMENT | 5 | 128 | 0.0008024 | 0.005507 |
679 | REGULATION OF DENDRITE MORPHOGENESIS | 4 | 74 | 0.0008199 | 0.005602 |
680 | CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 4 | 74 | 0.0008199 | 0.005602 |
681 | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 4 | 74 | 0.0008199 | 0.005602 |
682 | PROTEIN ACETYLATION | 5 | 129 | 0.0008311 | 0.00567 |
683 | REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 3 | 33 | 0.0008468 | 0.005769 |
684 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 8 | 352 | 0.0008756 | 0.005956 |
685 | RESPONSE TO EXTRACELLULAR STIMULUS | 9 | 441 | 0.0008972 | 0.006095 |
686 | FOREBRAIN NEURON DEVELOPMENT | 3 | 34 | 0.000925 | 0.006256 |
687 | REGULATION OF PROTEIN DEACETYLATION | 3 | 34 | 0.000925 | 0.006256 |
688 | NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 3 | 34 | 0.000925 | 0.006256 |
689 | MUSCLE TISSUE DEVELOPMENT | 7 | 275 | 0.0009625 | 0.0065 |
690 | RENAL TUBULE DEVELOPMENT | 4 | 78 | 0.000999 | 0.006737 |
691 | BONE REMODELING | 3 | 35 | 0.001008 | 0.006775 |
692 | RESPONSE TO MINERALOCORTICOID | 3 | 35 | 0.001008 | 0.006775 |
693 | ACTIN FILAMENT BASED PROCESS | 9 | 450 | 0.001034 | 0.00694 |
694 | NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 5 | 136 | 0.001053 | 0.007063 |
695 | REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 7 | 280 | 0.001069 | 0.007154 |
696 | POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 3 | 36 | 0.001095 | 0.007297 |
697 | POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 3 | 36 | 0.001095 | 0.007297 |
698 | HEAD MORPHOGENESIS | 3 | 36 | 0.001095 | 0.007297 |
699 | POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 4 | 81 | 0.00115 | 0.007646 |
700 | NUCLEAR ENVELOPE ORGANIZATION | 4 | 81 | 0.00115 | 0.007646 |
701 | POSITIVE REGULATION OF SECRETION | 8 | 370 | 0.001205 | 0.007999 |
702 | REGULATION OF DEFENSE RESPONSE | 12 | 759 | 0.001213 | 0.008041 |
703 | PROTEOLYSIS | 16 | 1208 | 0.001235 | 0.008176 |
704 | RESPONSE TO MECHANICAL STIMULUS | 6 | 210 | 0.001241 | 0.008203 |
705 | HAIR CYCLE | 4 | 83 | 0.001259 | 0.008289 |
706 | NIK NF KAPPAB SIGNALING | 4 | 83 | 0.001259 | 0.008289 |
707 | MOLTING CYCLE | 4 | 83 | 0.001259 | 0.008289 |
708 | NEGATIVE REGULATION OF AXON EXTENSION | 3 | 38 | 0.001283 | 0.008418 |
709 | SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 3 | 38 | 0.001283 | 0.008418 |
710 | ENDOMEMBRANE SYSTEM ORGANIZATION | 9 | 465 | 0.001298 | 0.008506 |
711 | POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 4 | 84 | 0.001317 | 0.008572 |
712 | CELLULAR RESPONSE TO OXYGEN LEVELS | 5 | 143 | 0.001317 | 0.008572 |
713 | RAS PROTEIN SIGNAL TRANSDUCTION | 5 | 143 | 0.001317 | 0.008572 |
714 | REGULATION OF PROTEIN COMPLEX ASSEMBLY | 8 | 375 | 0.001312 | 0.008572 |
715 | NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 5 | 143 | 0.001317 | 0.008572 |
716 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 6 | 213 | 0.001335 | 0.008672 |
717 | RESPONSE TO INTERFERON GAMMA | 5 | 144 | 0.001359 | 0.008816 |
718 | NEGATIVE REGULATION OF CELL CYCLE PROCESS | 6 | 214 | 0.001367 | 0.008857 |
719 | REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 4 | 85 | 0.001376 | 0.008879 |
720 | REGULATION OF CHROMOSOME SEGREGATION | 4 | 85 | 0.001376 | 0.008879 |
721 | EPHRIN RECEPTOR SIGNALING PATHWAY | 4 | 85 | 0.001376 | 0.008879 |
722 | POSITIVE REGULATION OF VIRAL TRANSCRIPTION | 3 | 39 | 0.001384 | 0.008895 |
723 | REGULATION OF AXON GUIDANCE | 3 | 39 | 0.001384 | 0.008895 |
724 | TRABECULA MORPHOGENESIS | 3 | 39 | 0.001384 | 0.008895 |
725 | REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS | 5 | 145 | 0.001401 | 0.00899 |
726 | RESPONSE TO ESTRADIOL | 5 | 146 | 0.001444 | 0.009242 |
727 | T CELL RECEPTOR SIGNALING PATHWAY | 5 | 146 | 0.001444 | 0.009242 |
728 | MAMMARY GLAND MORPHOGENESIS | 3 | 40 | 0.00149 | 0.009511 |
729 | FORELIMB MORPHOGENESIS | 3 | 40 | 0.00149 | 0.009511 |
730 | RESPONSE TO ESTROGEN | 6 | 218 | 0.001502 | 0.009573 |
731 | SINGLE ORGANISM BEHAVIOR | 8 | 384 | 0.001524 | 0.009703 |
732 | POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 4 | 88 | 0.001564 | 0.009942 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | BETA CATENIN BINDING | 20 | 84 | 1.5e-27 | 1.103e-24 |
2 | FRIZZLED BINDING | 16 | 36 | 2.374e-27 | 1.103e-24 |
3 | WNT ACTIVATED RECEPTOR ACTIVITY | 14 | 22 | 4.517e-27 | 1.399e-24 |
4 | WNT PROTEIN BINDING | 14 | 31 | 3.593e-24 | 8.344e-22 |
5 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 23 | 445 | 5.096e-16 | 9.469e-14 |
6 | ENZYME BINDING | 38 | 1737 | 8.493e-14 | 1.315e-11 |
7 | PROTEIN KINASE ACTIVITY | 24 | 640 | 1.309e-13 | 1.737e-11 |
8 | RECEPTOR AGONIST ACTIVITY | 7 | 16 | 1.67e-12 | 1.552e-10 |
9 | TRANSCRIPTION FACTOR BINDING | 21 | 524 | 1.536e-12 | 1.552e-10 |
10 | G PROTEIN COUPLED RECEPTOR BINDING | 16 | 259 | 1.423e-12 | 1.552e-10 |
11 | SIGNAL TRANSDUCER ACTIVITY | 35 | 1731 | 1.074e-11 | 9.068e-10 |
12 | KINASE ACTIVITY | 24 | 842 | 4.313e-11 | 3.082e-09 |
13 | PROTEIN DOMAIN SPECIFIC BINDING | 21 | 624 | 4.097e-11 | 3.082e-09 |
14 | RECEPTOR ACTIVATOR ACTIVITY | 7 | 32 | 4.562e-10 | 2.825e-08 |
15 | RECEPTOR BINDING | 30 | 1476 | 4.334e-10 | 2.825e-08 |
16 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 24 | 992 | 1.191e-09 | 6.915e-08 |
17 | REGULATORY REGION NUCLEIC ACID BINDING | 21 | 818 | 5.441e-09 | 2.901e-07 |
18 | MOLECULAR FUNCTION REGULATOR | 27 | 1353 | 5.934e-09 | 2.901e-07 |
19 | RECEPTOR REGULATOR ACTIVITY | 7 | 45 | 5.79e-09 | 2.901e-07 |
20 | ARMADILLO REPEAT DOMAIN BINDING | 5 | 13 | 6.538e-09 | 3.037e-07 |
21 | KINASE BINDING | 18 | 606 | 8.363e-09 | 3.7e-07 |
22 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 14 | 371 | 2.331e-08 | 9.841e-07 |
23 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 12 | 264 | 3.306e-08 | 1.335e-06 |
24 | PDZ DOMAIN BINDING | 8 | 90 | 4.263e-08 | 1.65e-06 |
25 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 17 | 629 | 8.879e-08 | 3.299e-06 |
26 | PROTEIN DIMERIZATION ACTIVITY | 23 | 1149 | 9.4e-08 | 3.359e-06 |
27 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 8 | 104 | 1.327e-07 | 4.566e-06 |
28 | SMAD BINDING | 7 | 72 | 1.658e-07 | 5.501e-06 |
29 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 12 | 315 | 2.258e-07 | 7.235e-06 |
30 | GAMMA CATENIN BINDING | 4 | 12 | 4.618e-07 | 1.43e-05 |
31 | CALMODULIN BINDING | 9 | 179 | 8.092e-07 | 2.425e-05 |
32 | MAP KINASE ACTIVITY | 4 | 14 | 9.257e-07 | 2.688e-05 |
33 | RIBONUCLEOTIDE BINDING | 28 | 1860 | 1.102e-06 | 3.102e-05 |
34 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 11 | 328 | 2.563e-06 | 7.003e-05 |
35 | ADENYL NUCLEOTIDE BINDING | 24 | 1514 | 3.193e-06 | 8.474e-05 |
36 | PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY | 4 | 21 | 5.369e-06 | 0.0001348 |
37 | SEQUENCE SPECIFIC DNA BINDING | 19 | 1037 | 5.289e-06 | 0.0001348 |
38 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 9 | 226 | 5.525e-06 | 0.0001351 |
39 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 14 | 588 | 5.838e-06 | 0.0001391 |
40 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 8 | 172 | 6.04e-06 | 0.0001403 |
41 | R SMAD BINDING | 4 | 23 | 7.874e-06 | 0.0001784 |
42 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 20 | 1199 | 1.165e-05 | 0.0002576 |
43 | CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 4 | 28 | 1.781e-05 | 0.0003761 |
44 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 5 | 57 | 1.745e-05 | 0.0003761 |
45 | DOUBLE STRANDED DNA BINDING | 15 | 764 | 2.614e-05 | 0.0005396 |
46 | PHOSPHOLIPASE C ACTIVITY | 4 | 31 | 2.702e-05 | 0.0005457 |
47 | I SMAD BINDING | 3 | 11 | 2.804e-05 | 0.0005542 |
48 | PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 5 | 64 | 3.079e-05 | 0.0005959 |
49 | CHROMATIN BINDING | 11 | 435 | 3.608e-05 | 0.000684 |
50 | CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 3 | 12 | 3.723e-05 | 0.0006917 |
51 | PHOSPHORIC ESTER HYDROLASE ACTIVITY | 10 | 368 | 4.553e-05 | 0.0008293 |
52 | TRANSCRIPTION COACTIVATOR ACTIVITY | 9 | 296 | 4.692e-05 | 0.0008382 |
53 | RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 4 | 36 | 4.95e-05 | 0.0008676 |
54 | PROTEIN HOMODIMERIZATION ACTIVITY | 14 | 722 | 5.672e-05 | 0.0009758 |
55 | PROTEIN HETERODIMERIZATION ACTIVITY | 11 | 468 | 6.968e-05 | 0.001177 |
56 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 3 | 15 | 7.605e-05 | 0.001262 |
57 | RHO GTPASE BINDING | 5 | 78 | 8.007e-05 | 0.001305 |
58 | PROTEIN KINASE C ACTIVITY | 3 | 16 | 9.321e-05 | 0.001493 |
59 | ENZYME REGULATOR ACTIVITY | 16 | 959 | 9.662e-05 | 0.001521 |
60 | PHOSPHATASE REGULATOR ACTIVITY | 5 | 87 | 0.0001346 | 0.002084 |
61 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 5 | 92 | 0.0001752 | 0.002668 |
62 | ENHANCER BINDING | 5 | 93 | 0.0001843 | 0.002762 |
63 | MACROMOLECULAR COMPLEX BINDING | 19 | 1399 | 0.0003024 | 0.00446 |
64 | MITOGEN ACTIVATED PROTEIN KINASE BINDING | 3 | 24 | 0.000326 | 0.004732 |
65 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 6 | 168 | 0.0003867 | 0.005443 |
66 | DRUG BINDING | 5 | 109 | 0.0003857 | 0.005443 |
67 | IDENTICAL PROTEIN BINDING | 17 | 1209 | 0.0004388 | 0.006084 |
68 | BHLH TRANSCRIPTION FACTOR BINDING | 3 | 28 | 0.000519 | 0.007074 |
69 | PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 6 | 178 | 0.0005254 | 0.007074 |
70 | P53 BINDING | 4 | 67 | 0.000563 | 0.007471 |
71 | NF KAPPAB BINDING | 3 | 30 | 0.000638 | 0.008347 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT SIGNALOSOME | 8 | 11 | 1.313e-16 | 7.669e-14 |
2 | BETA CATENIN DESTRUCTION COMPLEX | 8 | 14 | 2.357e-15 | 6.881e-13 |
3 | ENDOCYTIC VESICLE MEMBRANE | 13 | 152 | 3.355e-12 | 6.532e-10 |
4 | PHOSPHATASE COMPLEX | 9 | 48 | 5.92e-12 | 8.643e-10 |
5 | CATALYTIC COMPLEX | 26 | 1038 | 9.908e-11 | 1.157e-08 |
6 | PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 6 | 20 | 1.034e-09 | 1.006e-07 |
7 | ENDOCYTIC VESICLE | 13 | 256 | 2.251e-09 | 1.878e-07 |
8 | CHROMOSOME | 22 | 880 | 3.616e-09 | 2.64e-07 |
9 | NUCLEAR CHROMATIN | 13 | 291 | 1.05e-08 | 6.813e-07 |
10 | TRANSCRIPTION FACTOR COMPLEX | 13 | 298 | 1.393e-08 | 8.135e-07 |
11 | CHROMATIN | 15 | 441 | 2.812e-08 | 1.493e-06 |
12 | SYNAPSE | 18 | 754 | 2.269e-07 | 1.104e-05 |
13 | EXTRACELLULAR MATRIX | 13 | 426 | 8.626e-07 | 3.598e-05 |
14 | PROTEINACEOUS EXTRACELLULAR MATRIX | 12 | 356 | 8.29e-07 | 3.598e-05 |
15 | VESICLE MEMBRANE | 14 | 512 | 1.173e-06 | 4.568e-05 |
16 | TRANSCRIPTIONAL REPRESSOR COMPLEX | 6 | 74 | 3.857e-06 | 0.0001408 |
17 | CELL SURFACE | 16 | 757 | 5.466e-06 | 0.0001878 |
18 | INTRACELLULAR VESICLE | 21 | 1259 | 6.795e-06 | 0.0002205 |
19 | CYTOPLASMIC VESICLE PART | 14 | 601 | 7.485e-06 | 0.0002301 |
20 | NUCLEAR CHROMOSOME | 13 | 523 | 8.15e-06 | 0.000238 |
21 | PROTEIN KINASE COMPLEX | 6 | 90 | 1.205e-05 | 0.000335 |
22 | GOLGI LUMEN | 6 | 94 | 1.547e-05 | 0.0004106 |
23 | SCF UBIQUITIN LIGASE COMPLEX | 4 | 34 | 3.931e-05 | 0.000994 |
24 | TRANSFERASE COMPLEX | 14 | 703 | 4.255e-05 | 0.000994 |
25 | SYNAPSE PART | 13 | 610 | 4.089e-05 | 0.000994 |
26 | CYTOSKELETAL PART | 21 | 1436 | 4.85e-05 | 0.001089 |
27 | LAMELLIPODIUM | 7 | 172 | 5.531e-05 | 0.001196 |
28 | CHROMOSOME CENTROMERIC REGION | 7 | 174 | 5.95e-05 | 0.001241 |
29 | CYTOSKELETON | 25 | 1967 | 8.374e-05 | 0.001644 |
30 | NUCLEAR TRANSCRIPTION FACTOR COMPLEX | 6 | 127 | 8.446e-05 | 0.001644 |
31 | MICROTUBULE CYTOSKELETON | 17 | 1068 | 0.0001017 | 0.001917 |
32 | NUCLEAR ENVELOPE | 10 | 416 | 0.0001256 | 0.002291 |
33 | EXCITATORY SYNAPSE | 7 | 197 | 0.0001294 | 0.002291 |
34 | LATERAL PLASMA MEMBRANE | 4 | 50 | 0.0001821 | 0.003038 |
35 | NUCLEOPLASM PART | 13 | 708 | 0.0001821 | 0.003038 |
36 | NUCLEAR MEMBRANE | 8 | 280 | 0.0001921 | 0.003116 |
37 | MICROTUBULE ORGANIZING CENTER | 12 | 623 | 0.0002112 | 0.003333 |
38 | NEURONAL POSTSYNAPTIC DENSITY | 4 | 53 | 0.0002285 | 0.003512 |
39 | CELL PROJECTION | 22 | 1786 | 0.0003763 | 0.005635 |
40 | CENTROSOME | 10 | 487 | 0.0004423 | 0.006458 |
41 | ACTIN FILAMENT | 4 | 70 | 0.0006648 | 0.009469 |
42 | NEURON PART | 17 | 1265 | 0.0007318 | 0.009713 |
43 | SARCOLEMMA | 5 | 125 | 0.0007209 | 0.009713 |
44 | CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 3 | 31 | 0.0007034 | 0.009713 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04310_Wnt_signaling_pathway | 113 | 151 | 2.181e-266 | 3.926e-264 | |
2 | hsa04916_Melanogenesis | 42 | 101 | 2.453e-70 | 2.207e-68 | |
3 | hsa04390_Hippo_signaling_pathway | 42 | 154 | 4.692e-61 | 2.815e-59 | |
4 | hsa04340_Hedgehog_signaling_pathway | 19 | 56 | 1.42e-29 | 6.39e-28 | |
5 | hsa04720_Long.term_potentiation | 19 | 70 | 1.994e-27 | 7.177e-26 | |
6 | hsa04520_Adherens_junction | 17 | 73 | 2.368e-23 | 7.103e-22 | |
7 | hsa04114_Oocyte_meiosis | 19 | 114 | 5.217e-23 | 1.342e-21 | |
8 | hsa04912_GnRH_signaling_pathway | 17 | 101 | 9.427e-21 | 2.121e-19 | |
9 | hsa04010_MAPK_signaling_pathway | 21 | 268 | 2.483e-18 | 4.967e-17 | |
10 | hsa04971_Gastric_acid_secretion | 14 | 74 | 5.061e-18 | 9.109e-17 | |
11 | hsa04662_B_cell_receptor_signaling_pathway | 14 | 75 | 6.193e-18 | 1.013e-16 | |
12 | hsa04370_VEGF_signaling_pathway | 14 | 76 | 7.557e-18 | 1.134e-16 | |
13 | hsa04020_Calcium_signaling_pathway | 17 | 177 | 1.741e-16 | 2.41e-15 | |
14 | hsa04360_Axon_guidance | 15 | 130 | 7.22e-16 | 9.283e-15 | |
15 | hsa04510_Focal_adhesion | 17 | 200 | 1.373e-15 | 1.648e-14 | |
16 | hsa04350_TGF.beta_signaling_pathway | 13 | 85 | 1.548e-15 | 1.741e-14 | |
17 | hsa04012_ErbB_signaling_pathway | 13 | 87 | 2.123e-15 | 2.248e-14 | |
18 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 14 | 136 | 3.537e-14 | 3.537e-13 | |
19 | hsa04660_T_cell_receptor_signaling_pathway | 13 | 108 | 3.875e-14 | 3.671e-13 | |
20 | hsa04270_Vascular_smooth_muscle_contraction | 13 | 116 | 9.974e-14 | 8.976e-13 | |
21 | hsa04062_Chemokine_signaling_pathway | 14 | 189 | 3.38e-12 | 2.897e-11 | |
22 | hsa04722_Neurotrophin_signaling_pathway | 12 | 127 | 7.278e-12 | 5.955e-11 | |
23 | hsa04110_Cell_cycle | 12 | 128 | 7.994e-12 | 6.256e-11 | |
24 | hsa04970_Salivary_secretion | 10 | 89 | 7.738e-11 | 5.803e-10 | |
25 | hsa04540_Gap_junction | 10 | 90 | 8.664e-11 | 6.238e-10 | |
26 | hsa04380_Osteoclast_differentiation | 11 | 128 | 1.597e-10 | 1.106e-09 | |
27 | hsa04730_Long.term_depression | 9 | 70 | 2.07e-10 | 1.38e-09 | |
28 | hsa04972_Pancreatic_secretion | 9 | 101 | 5.749e-09 | 3.696e-08 | |
29 | hsa04014_Ras_signaling_pathway | 12 | 236 | 9.522e-09 | 5.91e-08 | |
30 | hsa04664_Fc_epsilon_RI_signaling_pathway | 8 | 79 | 1.511e-08 | 9.064e-08 | |
31 | hsa04710_Circadian_rhythm_._mammal | 5 | 23 | 1.634e-07 | 9.487e-07 | |
32 | hsa04070_Phosphatidylinositol_signaling_system | 7 | 78 | 2.892e-07 | 1.627e-06 | |
33 | hsa04670_Leukocyte_transendothelial_migration | 8 | 117 | 3.306e-07 | 1.803e-06 | |
34 | hsa04151_PI3K_AKT_signaling_pathway | 12 | 351 | 7.143e-07 | 3.781e-06 | |
35 | hsa04530_Tight_junction | 8 | 133 | 8.815e-07 | 4.534e-06 | |
36 | hsa04330_Notch_signaling_pathway | 5 | 47 | 6.686e-06 | 3.343e-05 | |
37 | hsa04914_Progesterone.mediated_oocyte_maturation | 6 | 87 | 9.906e-06 | 4.819e-05 | |
38 | hsa04210_Apoptosis | 6 | 89 | 1.13e-05 | 5.351e-05 | |
39 | hsa04910_Insulin_signaling_pathway | 7 | 138 | 1.343e-05 | 6.199e-05 | |
40 | hsa04620_Toll.like_receptor_signaling_pathway | 6 | 102 | 2.466e-05 | 0.000111 | |
41 | hsa04810_Regulation_of_actin_cytoskeleton | 8 | 214 | 2.947e-05 | 0.0001294 | |
42 | hsa03015_mRNA_surveillance_pathway | 5 | 83 | 0.0001077 | 0.0004615 | |
43 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 5 | 95 | 0.0002036 | 0.0008525 | |
44 | hsa04742_Taste_transduction | 4 | 52 | 0.0002122 | 0.0008681 | |
45 | hsa04630_Jak.STAT_signaling_pathway | 6 | 155 | 0.0002511 | 0.001004 | |
46 | hsa00562_Inositol_phosphate_metabolism | 4 | 57 | 0.000303 | 0.001186 | |
47 | hsa04621_NOD.like_receptor_signaling_pathway | 4 | 59 | 0.0003461 | 0.001325 | |
48 | hsa04115_p53_signaling_pathway | 4 | 69 | 0.0006295 | 0.002361 | |
49 | hsa04622_RIG.I.like_receptor_signaling_pathway | 4 | 71 | 0.0007014 | 0.002577 | |
50 | hsa04120_Ubiquitin_mediated_proteolysis | 5 | 139 | 0.001161 | 0.00418 | |
51 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 3 | 42 | 0.001717 | 0.006061 | |
52 | hsa04962_Vasopressin.regulated_water_reabsorption | 3 | 44 | 0.001965 | 0.006802 | |
53 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 5 | 168 | 0.002666 | 0.009055 | |
54 | hsa04740_Olfactory_transduction | 7 | 388 | 0.006526 | 0.02175 | |
55 | hsa04920_Adipocytokine_signaling_pathway | 3 | 68 | 0.006742 | 0.02206 | |
56 | hsa04976_Bile_secretion | 3 | 71 | 0.007595 | 0.02441 | |
57 | hsa04973_Carbohydrate_digestion_and_absorption | 2 | 44 | 0.02565 | 0.08101 | |
58 | hsa03008_Ribosome_biogenesis_in_eukaryotes | 2 | 81 | 0.07687 | 0.2386 | |
59 | hsa04144_Endocytosis | 3 | 203 | 0.1078 | 0.3289 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | MEG3 |
hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-592;hsa-miR-616-5p;hsa-miR-629-3p;hsa-miR-7-1-3p | 19 | PRICKLE2 | Sponge network | -1.645 | 0.00049 | -2.154 | 0 | 0.479 |
2 | AGAP11 |
hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-140-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-3662;hsa-miR-500a-3p | 14 | DAAM1 | Sponge network | -1.728 | 0.00016 | -0.57 | 0.03626 | 0.478 |
3 | KCNQ1OT1 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-100-5p;hsa-miR-149-5p;hsa-miR-181a-2-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-296-5p;hsa-miR-744-3p;hsa-miR-9-5p | 11 | FZD5 | Sponge network | -0.725 | 0.08874 | -0.562 | 0.20161 | 0.449 |
4 | CASC2 |
hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-218-5p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-24-2-5p;hsa-miR-369-3p;hsa-miR-452-5p;hsa-miR-654-3p;hsa-miR-944 | 12 | PRKCA | Sponge network | -0.561 | 0.05962 | -0.525 | 0.15685 | 0.436 |
5 | EMX2OS |
hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33b-5p;hsa-miR-589-3p;hsa-miR-592;hsa-miR-7-1-3p | 14 | PRICKLE2 | Sponge network | -1.088 | 0.10042 | -2.154 | 0 | 0.415 |
6 | KCNQ1OT1 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p | 11 | NLK | Sponge network | -0.725 | 0.08874 | 0.087 | 0.60941 | 0.392 |
7 | PCA3 |
hsa-miR-141-5p;hsa-miR-16-2-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-452-3p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-616-5p | 12 | PRKCB | Sponge network | -2.778 | 8.0E-5 | -1.403 | 0.00367 | 0.387 |
8 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-219a-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-708-5p;hsa-miR-940 | 28 | FZD4 | Sponge network | -2.778 | 8.0E-5 | -1.774 | 0 | 0.38 |
9 | PCA3 |
hsa-let-7f-1-3p;hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-221-5p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3662;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-629-3p | 30 | PRICKLE2 | Sponge network | -2.778 | 8.0E-5 | -2.154 | 0 | 0.374 |
10 | PART1 |
hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-2110;hsa-miR-3614-5p;hsa-miR-362-5p;hsa-miR-501-5p;hsa-miR-7-1-3p | 10 | VANGL2 | Sponge network | -2.298 | 0.00168 | -0.012 | 0.98605 | 0.367 |
11 | CASC2 |
hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-342-3p | 10 | NLK | Sponge network | -0.561 | 0.05962 | 0.087 | 0.60941 | 0.352 |
12 | MALAT1 | hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-15b-5p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-92b-3p | 13 | FZD4 | Sponge network | -1.099 | 0.0005 | -1.774 | 0 | 0.338 |
13 | AGAP11 |
hsa-let-7f-1-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-362-5p;hsa-miR-3662;hsa-miR-421;hsa-miR-590-5p;hsa-miR-629-3p | 21 | PRICKLE2 | Sponge network | -1.728 | 0.00016 | -2.154 | 0 | 0.332 |
14 | KCNQ1OT1 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-708-5p | 10 | FZD4 | Sponge network | -0.725 | 0.08874 | -1.774 | 0 | 0.329 |
15 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-181a-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-19b-3p;hsa-miR-224-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p | 20 | CCND2 | Sponge network | -2.778 | 8.0E-5 | -0.496 | 0.3 | 0.318 |
16 | RFPL1S |
hsa-miR-144-3p;hsa-miR-148b-5p;hsa-miR-19b-1-5p;hsa-miR-26b-5p;hsa-miR-335-5p;hsa-miR-338-3p;hsa-miR-3614-5p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-7-1-3p | 10 | CAMK2A | Sponge network | -0.223 | 0.70704 | -0.131 | 0.82753 | 0.31 |
17 | MEG3 |
hsa-let-7d-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-629-3p | 16 | FZD4 | Sponge network | -1.645 | 0.00049 | -1.774 | 0 | 0.304 |
18 | PLAC4 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p | 11 | NLK | Sponge network | -0.563 | 0.27163 | 0.087 | 0.60941 | 0.302 |
19 | HCG18 | hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p | 11 | NLK | Sponge network | -0.24 | 0.23472 | 0.087 | 0.60941 | 0.285 |
20 | AGAP11 |
hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-212-3p;hsa-miR-26b-3p;hsa-miR-320b | 11 | NFAT5 | Sponge network | -1.728 | 0.00016 | -0.044 | 0.82158 | 0.278 |
21 | PCA3 |
hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-200c-3p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-369-3p;hsa-miR-590-3p;hsa-miR-93-3p;hsa-miR-944 | 11 | PRKCA | Sponge network | -2.778 | 8.0E-5 | -0.525 | 0.15685 | 0.278 |
22 | PLAC4 |
hsa-let-7a-3p;hsa-let-7b-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-455-3p;hsa-miR-708-5p;hsa-miR-940 | 10 | FZD4 | Sponge network | -0.563 | 0.27163 | -1.774 | 0 | 0.277 |
23 | DGCR5 | hsa-miR-107;hsa-miR-126-5p;hsa-miR-148a-5p;hsa-miR-2110;hsa-miR-30d-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-577;hsa-miR-592;hsa-miR-652-3p | 10 | CSNK1A1 | Sponge network | 1.383 | 0.01835 | -0.125 | 0.51313 | 0.276 |
24 | EMX2OS |
hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-500a-3p;hsa-miR-577;hsa-miR-92a-3p;hsa-miR-92b-3p | 13 | DAAM1 | Sponge network | -1.088 | 0.10042 | -0.57 | 0.03626 | 0.274 |
25 | RFPL1S |
hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-7-1-3p | 10 | PRICKLE2 | Sponge network | -0.223 | 0.70704 | -2.154 | 0 | 0.273 |
26 | CASC2 |
hsa-let-7a-3p;hsa-let-7b-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-708-5p;hsa-miR-940 | 11 | FZD4 | Sponge network | -0.561 | 0.05962 | -1.774 | 0 | 0.271 |
27 | FAM95B1 | hsa-miR-185-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-629-3p;hsa-miR-708-5p;hsa-miR-940 | 10 | FZD4 | Sponge network | -1.726 | 0.00466 | -1.774 | 0 | 0.268 |
28 | MEG3 |
hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-26b-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-652-3p | 12 | NFAT5 | Sponge network | -1.645 | 0.00049 | -0.044 | 0.82158 | 0.265 |
29 | PCA3 |
hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200c-3p;hsa-miR-330-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p | 11 | PRKACB | Sponge network | -2.778 | 8.0E-5 | -2.003 | 0 | 0.257 |
30 | MEG3 |
hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-429;hsa-miR-577 | 11 | DAAM1 | Sponge network | -1.645 | 0.00049 | -0.57 | 0.03626 | 0.252 |